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 Abstract 
 
The epithelial sodium channel (ENaC) is composed of three homologous subunits α, β, and γ. 
This channel is involved in the regulation of sodium balance, which influences the periciliary 
liquid level in the lung, and blood pressure via the kidney. ENaC expressed in Xenopus laevis 
oocytes is preferentially and rapidly assembled into heteromeric αβγ complexes. Expression 
of homomeric α or heteromeric αβ and αγ complexes lead to channel expression at the cell 
surface with low activities. Recent studies have demonstrated that α and γ (but not β) ENaC 
subunits undergo proteolytic cleavage by endogenous proteases (i.e. furin) correlating with 
increased channel activity. We therefore assayed the full-length subunits and their cleavage 
products at the cell surface, as well as in the intracellular pool for all homo- and heteromeric 
combinations (α, β, γ, βγ, αβ, αγ, βγ and αβγ) and measured the corresponding channel 
activities as amiloride-sensitive sodium transport (INa). We showed that upon assembly, 
cleavage of the γ ENaC subunit is responsible for increasing INa. We further demonstrated that 
in disease states such as cystic fibrosis (CF) where there is disequilibrium in the protease-
protease inhibitor balance, ENaC is over-activated by the serine protease elastase (NE). We 
demonstrated that elevated NE concentrations can cleave cell surface expressed  γ ENaC  (but 
not α, or β ENaC), suggesting a causal relationship between γ ENaC cleavage and ENaC 
activation, taking place at the plasma membrane. In addition, we demonstrated that the serine 
protease inhibitor (serpin) serpinH1, which is co-expressed with ENaC in the distal nephron is 
capable of inhibiting the channel by preventing cleavage of the γ ENaC subunit. Aldosterone 
mediated increases in INa are known to be inhibted by TGFβ. TGFβ is also known to increase 
serpinH1 expression. The demonstrated inhibition of γ ENaC cleavage and channel activation 
by serpinH1 may be responsible for the effect of TGFβ on aldosterone stimulation in the 
distal nephron. In summary, we show that cleavage of the  γ  subunit, but not the α or  β 
subunit is linked to channel activation in three seperate contexts. 
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Resume 
 
Le canal épithélial à sodium (ENaC) est constitué de trois sous-unités homologues α, β, and γ. 
Ce canal est impliqué dans le maintien de la balance sodique qui influence le niveau du 
liquide périciliaire du poumon et la pression sanguine via le rein. Dans les ovocytes de 
Xenopus laevis ENaC est préférentiellement et rapidement exprimé en formant un complexe 
hétéromérique αβγ. En revanche, l’expression homomérique de α ou hétéromérique des 
complexes αβ et αγ conduit à une expression à la surface cellulaire d’un canal ENaC ne 
possédant qu’une faible activité. Des études récentes ont mis en évidence que les sous-unités 
α et γ d’ENaC (mais pas β) sont coupées par des protéases endogènes (les furines) et que ces 
clivages augmentent l’activité du canal. Nous avons donc analysé, aussi bien à la surface 
cellulaire que dans le cytoplasme, les produits des clivages de combinaison homo- et 
hétéromérique des sous-unités d’ENaC (α, β, γ, βγ, αβ, αγ, βγ et αβγ). En parallèle, nous 
avons étudié l’activité correspondante à ces canaux par la mesure du transport de sodium 
sensible à l’amiloride (INa). Nous avons montré que lors de l’assemblage des sous-unités 
d’ENaC, le clivage de γ correspond à l’augmentation de INa. Nous avons également mis en 
évidence que dans une maladie telle que la fibrose cystique (CF) caractérisée par un 
déséquilibre de la balance protéase-inhibiteur de protéase, ENaC est suractivé par une sérine 
protéase nommée élastase (NE). L’augmentation de la concentration de NE clive γ ENaC 
exprimé à la surface cellulaire (mais pas α, ni β ENaC) suggérant une causalité entre le 
clivage d’ENaC et son activation à la membrane plasmique. De plus, nous avons démontré 
que l’inhibiteur de sérine protéase (serpin) serpinH1, qui est co-exprimé avec ENaC dans le 
néphron distal, inhibe l’activité du canal en empêchant le clivage de la sous-unité γ ENaC. Il 
est connu que le INa induit par l’aldostérone peut être inhibé par TGFβ. Or TGFβ augmente 
l’expression de serpinHI. L’inhibition du clivage de γ ENaC et de l’activation du canal par la 
serpinHI que nous avons mis en évidence pourrait ainsi être responsable de l’effet de TGFβ 
sur la stimulation du courant par l’aldostérone dans le néphron distal. En résumé, nous avons 
montré que le clivage de la sous-unité γ, mais pas des sous-unités α et β, est lié à l’activation 
du canal dans trois contextes distincts.  
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Resume tout public 
 
Le corps humain est composé d’environ 10 000 milliards de cellules et d’approximativement 
60% d’eau. Les cellules du corps sont les unités fondamentales de la vie et elles sont 
dépendantes de certains nutriments et molécules. Ces nutriments et molécules sont dissous 
dans l’eau qui est présente dans et hors des cellules. Le maintien d’une concentration adéquate 
de ces nutriments et de ces molécules dans l’eau à l’intérieur et à l’extérieur des cellules est 
essentiel pour leur survie. L’eau hors des cellules est nommée le fluide extracellulaire et peut 
être subdivisée en fluide interstitiel, qui se trouve autour des cellules, et en plasma, qui est le 
fluide des vaisseaux sanguins. Les fluides, les nutriments et les molécules sont constamment 
échangés entre les cellules, le fluide interstitiel, et le plasma. Le plasma circule dans le 
système circulatoire afin de distribuer les nutriments et molécules dans tout le corps et afin 
d’enlever les déchets cellulaires. Le rein joue un rôle essentiel dans la régulation du volume et 
de la concentration du plasma en éliminant sélectivement les nutriments et les molécules via 
la formation de l’urine. L’être humain possède deux reins, constitués chacun d’environ 1 
million de néphrons. Ces derniers sont responsables de réabsorber et de sécréter sélectivement 
les nutriments et les molécules. Le canal épithélial à sodium (ENaC) est localisé à la surface 
cellulaire des néphrons et est responsable de la réabsorption du sodium (Na+). Le Na+ est 
présent dans quasiment toute la nourriture que nous mangeons et représente, en terme de 
molécule, 50% du sel de cuisine. Si trop de sodium est consommé, ENaC est inactif, si bien 
que le Na+ n’est pas réabsorbé et quitte le corps par l’urine. Ce mécanisme permet d’éviter 
que la concentration plasmatique de Na+ ne devienne trop grande, ce qui résulterait en une 
augmentation de la pression sanguine. Si trop peu de Na+ est consommé, ENaC réabsorbe le 
Na+ de l’urine primaire ce qui permet de conserver la concentration de Na+ et de prévenir une 
diminution de la pression sanguine par une perte de Na+. ENaC est aussi présent dans les 
cellules des poumons qui sont les organes permettant la respiration. La respiration est aussi 
essentielle pour la survie des cellules. Les poumons ne doivent pas contenir trop de liquide 
afin de permettre la respiration, mais en même temps ils ne doivent pas non plus être trop 
secs. En effet, ceci tuerait les cellules et empêcherait aussi la respiration. ENaC permet de 
maintenir un niveau d’humidité approprié dans les poumons en absorbant du Na+ ce qui 
entraîne un mouvement osmotique d’eau. L’absorption de sodium par ENaC est augmentée 
par les protéases (in vitro et ex vivo). Les protéases sont des molécules qui peuvent couper 
d’autres molécules à des endroits précis. Nous avons démonté que certaines protéases 
augmentent l’absorption de Na+ en coupant ENaC à des endroits spécifiques. L’inhibition de 
ces protéases diminue le transport de Na+ et empêche le clivage d’ENaC. Dans certaines 
maladies telle que la mucoviscidose, des protéases sont suractivées et augmentent l’activité 
d’ENaC de manière inappropriée conduisant à une trop forte absorption de Na+ et à un 
déséquilibre de la muqueuse des poumons. Cette étude est donc particulièrement importante 
dans le cadre de la recherche thérapeutique de ce genre de maladie. 
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Abbreviations 
 
A  alanine 
AA  amino acid 
ACE  angiotensin converting enzyme 
Am  amiloride 
ANOVA  analysis of variance 
αPDX  α-1 antitrypsin Portland variant 
Apr  aprotinin 
ASDN  aldosterone sensitive distal nephron 
Asp  aspartic acid (also abbreviated as D) 
ATP  adenosine triphosphate 
C  cysteine 
C-  carboxy terminus 
Ca2+  calcium 
CaCl2  calcium chloride 
CAP  channel activating protease 
CCD  cortical collecting duct 
CF  cystic fibrosis 
CFTR  cystic fibrosis transmembrane conductance regulator 
CHO  Chinese hamster ovary cells 
Cl-   chloride 
CNT  connecting tubule 
CO2  carbon dioxide 
COPD  congestive obstructive pulmonary disease 
CRD  cysteine rich domain 
cRNA  complementary RNA 
D  aspartic acid 
DCT  distal convoluted tubule 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
E  glutamic acid 
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EDTA  ethylene-diamino-tetraacetate 
ENaC  epithelial sodium channel 
EPI-hNE4  engineered protein inhibitor of human neutrophil elastase 4 
ER  endoplasmic reticulum 
F  phenylalanine 
FaNaCh  FMRFamide-activated ion channel 
FRET  fluorescence resonance energy transfer 
g  gravity 
G  glycine 
Gly  glycine (also abbreviated as G) 
H  histidine 
H1  first hydrophobic domain of the ENaC subunits 
H2  second hydrophobic domain of the ENaC subunits 
hENaC  human epithelial sodium channel 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
I  isoleucine 
IC50  half maximal inhibitory concentration 
INa  amiloride-sensitive current 
Isc  short circuit current  
IMCD  inner medullary collecting duct 
K  lysine 
K+  potassium 
kD  kilodalton 
KCl  potasium 
H2O  water 
L  leucine 
M  methionine 
M1  first transmembrane domain of the ENaC subunits 
M2  second transmembrane domain of the ENaC subunits 
μA  microamperes 
MBS  modified Barth’s saline 
mCCD mouse cortical collecting duct cell line responsive to physiologic 
doses of aldosterone 
MDCK  Madin-Darby canine kidney cells 
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mENaC  mouse epithelial sodium channel 
MEROPS  protease database 
Mg2+  magnesium 
mmHg  millimeters of mercury 
mpkCCD  mouse cortical collecting duct cell line 
n  number of experimental repititions 
N  asparagine 
N-  amino terminus 
Na+  sodium 
Na+/K+-ATPase  sodium-potassium adenosine triphosphatase 
NE  neutrophil elastase 
Nedd4 neuronal precursor cell-expressed developmentally down-
regulated 4 
N.I.  non-injected 
NP40  nonidet-P40 
O2  oxygen 
p  probability 
P  proline 
PAGE  polyacrylamide gel electrophoresis 
PCT  proximal convoluted tubule 
Pn  amino terminal amino acid of a substrate of proteolysis 
Pn’  carboxy terminal amino acid of a substrate of proteolysis 
Po  open probability 
PHA-1  pseudohypoaldosteronism type 1 
PCR  polymerase chain reaction 
PCT  proximal convoluted tubule 
PMSF  phenylmethylsulfonyl fluoride 
Q  glutamine 
R  arginine 
rENaC  rat epithelial sodium channel 
Rn  amino acid n 
RNA  ribonucleic acid 
rpm  revolutions per minute 
RXXR  furin consensus motif 
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S  serine 
SAGE  serial analysis of gene expression 
SDS  sodium dodecyl sulfate 
Ser  serine (also abbreviated as S) 
Serpin  serine protease inhibitor 
SGK  serum and glucocorticoid regulated kinase 
T  threonine 
TBS  tris-buffered saline 
TGFβ  transforming growth factor β 
Thr  threonine (also abbreviated as T) 
Tmax  time to maximal channel activation 
Tris  tris-hydroxymethyl-amino-methane 
V  valine 
Val  valine (also abbreviated as V) 
W  tryptophan 
X  any amino acid 
Y   tyrosine 
Zn2+  zinc 
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INTRODUCTION 
The most abundant cation in the extracellular fluid is sodium (Na+), its concentration dictates 
the volume of fluid that is retained or secreted. When too much Na+ is retained, extracellular 
volume increases which leads to hypertension. Conversely, when too much Na+ is secreted, 
extracellular volume decreases leading to hypotension. The fine tuning of Na+ retention is 
controlled by the epithelial Na+ channel (ENaC). ENaC is composed of three subunits α, β, 
and γ, which permit highly selective Na+ transport across the apical membrane of epithelial 
cells. ENaC is expressed in the kidney, lung, sweat glands, colon, salivary glands, pancreas, 
liver, placenta, skin, stomach, and ear (1-4). ENaC has been most extensively studied in the 
kidney, where it is involved in Na+ retention and in the control of blood pressure, and in the 
lung, where it is involved in keeping the airspaces free of fluid so that gas exchange can 
occur. These are tissues where Na+ transport is imperative for the survival of the organism. 
The necessity of ENaC in these tissues has been confirmed by gene disruption studies, which 
showed that “knocking out” the α ENaC gene in mice resulted in impaired fluid transport in 
the lungs of newborn mice pups resulting in death immediately after birth. This rapid 
mortality did not allow delineation of the contribution of other organs such as the kidney, 
which were most likely also effected (5). Further evidence of the involvement of ENaC in the 
kidney and lung was shown in γ ENaC ‘knockout mice’, which demonstrated impaired lung 
fluid clearance secondary to major metabolic disturbances, caused by disrupted ion transport 
in the kidney, and lead to death 24-26 hours after birth (6). When β ENaC was knocked out in 
the mouse, death occurred 2 days after birth due to kidney specific metabolic dysregulation, 
and with little effect on the lung (7). Together, these gene disruption studies outlined the 
importance for α, β, and γ ENaC subunits in maintaining homeostasis in the kidney and lung 
above other tissues. The contribution of ENaC to the other tissues in which it is expressed 
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should not be discounted, but their analysis by whole animal gene disruption remains elusive 
due to the lethality of the lung, and kidney phenotypes. Tissue specific gene inactivation 
studies may help to clarify the role of the ENaC subnits in these other tissues. Such work has 
indicated that α ENaC is essential for epidermal differentiation, and skin specific knockout 
mice have a skin phenotype similar to psoriasis (8).  
A Brief History of Blood Pressure Physiology, Amiloride Pharmacology and 
ENaC. 
 
Professor Samuel von Basch first performed non-invasive and therefore clinically practical 
blood pressure measurement in 1881 when he invented the sphygmomanometer. It was he, at 
the University of Vienna who was credited with the first scientific observation of blood 
pressure in man. Subsequent use of the sphygmomanometer with the stethoscope, to hear the 
sound of blood flowing through the artery, by the Russian physician Nikolai Korotkoff in 
1905 led to more accurate measurements of blood pressure.  
 
Before the regulation of blood pressure was thouroughly understood, experiments by Arthur 
C. Guyton revealed that blood pressure tended towards equilibrium, and was regulated by the 
circulatory system and kidney. In his experiments, extreme volume overload by blood 
transfusion to 2.62 times normal values, over a prolonged period resulted in a paltry 17mmHg 
increase in blood pressure (9,10). These experients demonstrated the tremendous capacity of 
blood pressure regulation possible in mammals at infusion rates of less than 0.1 blood 
volumes per minute. When blood volume was increased more rapidly the ability to correct 
was limited by speed of compensation of circulatory volume by the pressoreceptor complex, 
which was on the order of 10-20 seconds (11). After large transfusions, large quantities of 
blood (65%) leave the circulation rapidly, forming interstitial fluid (2 minutes after infusion), 
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and re-enter the circulation very slowly (10).  These studies by Guyton demonstrated the role 
of the circulatory system in blood pressure regulation and helped to elucidate control of 
vascular tone by the baroreceptor reflex (then called the pressoreceptor).  
 
Guyton later studied the effect of urine formation on blood pressure. His study on the effects 
of epinephrine on blood pressure and urine formation revealed that epinephrine increased 
arterial pressure with increasing dosage. This effect of epinephrine on urine formation was 
biphasic due to its ability to increase arterial tension and reducing urine formation in the 
kidney (12). However, when blood pressure was kept constant, epinephrine decreased urine 
formation indicating the importance of the kidney on blood pressure regulation (12). Further 
experiments by Guyton showed that increasing aterial pressure resulted in increased renal 
blood flow, with increased urine formation as an effective regulator of arterial blood pressure 
and volume (13).  
 
Prior to the discovery of ENaC, it was demonstrated that, N-amidino-3-amino-6-
chloropyrazinecarboxamide, later named amiloride-HCL (amiloride), was able to decrease 
blood pressure by inhibiting Na+ transport, antagonizing the effects of aldosterone (14,15). 
Amiloride had an added advantage over previously discovered anti-hypertensive medications, 
it was capable of sparing potassium (K+) loss, an undesirable characteristic of thiazide 
diuretics (16). Thus, amiloride became a widely prescribed anti-hypertensive medication. 
However, the biological target of amiloride remained unknown for 30 years until the cloning 
of ENaC in 1993, and subsequent identification of the amiloride binding site in 1997, both of 
which occurred in the Department of Pharmacology at the University of Lausanne (17,18). 
The discovery of urine formation as a key regulator of blood pressure, amiloride as an 
inhibitor of Na+ transport in the kidney, and the cloning of ENaC are the key historical events 
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that have implicated ENaC as an essential mediator of blood pressure regulation. 
 
The Lung 
 
The lungs are the respiratory organs of air breathing vertebrates, which lie on either side of 
the thoracic cavity, and connect via the trachea, larynx, pharynx, nose, and mouth to the 
external environment. The lungs consist of a continually branching network of air conducting 
tubules, starting at the primary bronchi, and terminating with the alveoli. Gas exchange occurs 
across the epithelium of the most distal airways (respiratory bronchioles) and the alveoli.  The 
lungs are responsible for gas exchange, and essential for the support of oxidative metabolism 
of food (e.g. carbohydrates, fats, protein) by O2 to produce CO2, H2O and energy in the form 
of ATP. The lung supports this reaction by absorbing O2 from the environment and excreting 
CO2, and thereby maintaining the homeostatic equilibrium.  
 
In order for gas exchange to occur, the lungs need to remain free of fluid. However, during 
the development of the lung in-utero the lungs are fluid filled, and this fluid is essential for 
normal lung development (19). The distal lung epithelium is polarized and capable of 
vectorial transport of H2O and ions such as Na+ and Cl-. The fetal lung secretes Cl- driving the 
production of fetal lung fluid (20). This epithelium is converted at birth from a net secretion 
of Cl- to a net absorption of Na+. This change in vectorial ion transport converts the distal 
lung from a fluid secreting to a fluid absorbing epithelium. This fluid clearance at birth is 
essential, so that air breathing can begin (21). Amiloride-sensitive Na+ absorption was 
identified in-vivo as the main mechanism for clearance of liquid from the fetal lamb lung (22), 
implicating ENaC as the essential Na+ channel for clearance of lung fluid. The role of ENaC 
in fluid absorption in the lung was confirmed by α, and γ ENaC gene disruption studies that 
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resulted in fetal mortality due to pulmonary insufficiency (5,6), and by airway specific 
overexpression of the β ENaC subunit which resulted in pathologic hyperabsorptive lung 
epithelium (23). 
 
The Kidney  
 
The kidneys are bean shaped excretory organs in vertebrates which filter waste from blood to 
form urine. Two kidneys lie on either side of the spine (Figure 1). The lateral aspect of the 
kidney is the cortex and the medial is the medulla. There is an opening on the medial side of 
the medulla called the hilum, which provides passage for the renal artery, the renal vein, 
nerves, and the ureter. The kidney receives its blood supply from the renal artery, which 
branches from the abdominal aorta. Distal to the entry of the hilum of the kidney, the renal 
artery divides several times into smaller arteries and eventually gives rise to the afferent 
arterioles supplying the glomerular capillaries. Glomerular capillaries drain into efferent 
arterioles that divide into peritubular capillaries that provide blood supply to the cortex. Blood 
from these capillaries collects in renal venules and leaves the kidney via the renal vein. 
Efferent arterioles of glomeruli closest to the medulla (those that belong to juxtamedullary 
nephrons) send branches into the medulla, forming the vasa recta. The kidney is composed of 
many nephron’s which are the basic functional units that regulate water and electrolyte levels 
in the body by selectively reabsorbing fluid and electrolytes. Waste products that are filtered 
from the blood and not reabsorbed enter the collecting duct and drain into the ducts of bellini, 
and exit the kidney via the ureter. 
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Figure 1: The kidneys are a pair of bean shaped excretory organs located on either side of the 
abdominal cavity. From (24). 
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The Nephron 
 
The nephron is the basic functional unit of the kidney, which regulates water and electrolyte 
levels in the body by filtering blood under pressure from the glomerular capillaries, and 
reabsorbing fluid and electrolytes that are necessary, while excreting fluid and electrolytes 
that are unnecessary (Figure 2). The substances that are filtered and selectively absorbed in 
the nephron include H2O, inorganic ions (e.x. Na+, Cl–, K+, Ca2+, and Mg2+), phosphate, 
bicarbonate, and organic molecules (e.x. urea, glucose, amino acids, lactate, and peptides). 
The regulation of fluid and electrolyte balance is achieved by the endocrine system, which 
secretes hormones such as aldosterone and vasopressin, depending on the needs of the 
organism. There are two types of nephrons, the juxtamedullary nephron (15%) and the 
cortical nephron (85%). The nephron begins with the renal corpuscle, which contains the 
glomerulus and is responsible for the initial filtering of the blood, and is followed by the 
tubule that is responsible for absorpion and secretion.  
 
The glomerulus filters blood allowing molecules with a radius of less than 1.8nm (which 
corresponds with a molecular mass of approximately 10kD) to freely pass through the filter 
into the tubule of the nephron. Molecules with radius of greater than 4.4nm (molecular mass 
of approximately 80kD) cannot pass through this filter and remain in the circulatory system. 
Variation in the resisitance of the afferent and efferent arterioles which control pressure in the 
glomerulus, in turn control the amount of fluid that is filtered by the kidneys (when blood 
pressure is between approximately 80 and 180mmHg), which is referred to as the glomerular 
filtration rate. The normal amount of fluid that is filtered by the glomerulus in a normal 
human is approximately 180L/day. Reabsorption in the tubule is responsible for recovering 
99% of this filtrate resulting in normal daily urination of 1.8L/day. 
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Figure 2: The nephron is the basic functional unit of the kidney which regulates water and 
electrolyte levels in the body. The segments of the nephron include the proximal tubule (1st 
convoluted tubule), loop of henle, distal convoluted tubule (2nd convoluted tubule), and 
connecting tubule (junction tubule). The nephron delivers its filtrate to the collecting duct 
(collecting tubule). From (24). 
 
The tubule can be broken down into several segments with different functions and anatomical 
characteristics. These segments are the proximal convoluted tubule (PCT), loop of henle, 
distal convoluted tubule (DCT), and the connecting tubule (CNT).  The nephron tubule 
delivers its filtrate to the collecting duct. Althought the collecting duct is considered 
anatomically different from the nephron, here we refer to the nephron as the tubule and the 
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collecting duct. The cells of the nephron are polar, meaning they have significantly different 
properties on their apical (urinary lumen) pole compared to their basolateral pole (blood side). 
The apical membrane of the proximal tubule cells has a high brush border composed of 
microvilli that greatly increase the surface area of these cells, and therefore allow greater 
absorptive capacity. Approximately two-thirds of the filtered salt and water are reabsorbed in 
the proximal tubule, as well as all of the organic solutes such as glucose and the amino acids. 
Peptides such as angiotensin II are broken down so quickly by the luminal proteases of the 
brush border that they can be freely absorbed in this nephron segement as amino acids. The 
remainder of the tubular segments do not have this brush border and consequently don’t 
absorb as much as this initial tubular segment which has a surface area of 100m2 in humans. 
The intercellular connections or tight junctions in the proximal tubule are not as “tight” as in 
more distal nephron segments allowing high rates of paracellular ion and fluid transport.  
 
The proximal tubule lies in the cortex of the kidney and is followed by the loop of Henle, 
which receives filtrate from the proximal tubule in the cortex and descends into the medulla 
before returning to the cortex forming a U-shaped loop. The loop of Henle can be divided into 
the descending loop and ascending loop, which have opposite properties in certain respects. 
The descending loop of Henle is highly impermeable to Na+ but permeable to H2O due to the 
presence of aquaporins, whereas the ascending loop of Henle is impermeable to H2O but 
actively absorbs Na+. This combination of transport properties in the loop of Henle gives rise 
to the countercurrent exchange mechanism where H2O leaves the lumen in the descending 
limb concentrating the urine, and Na+ is actively pumped out of the concentrated urine in the 
ascending limb resulting in the absorption of both Na+ and H2O. The osmotic gradient 
produced by the interstitial Na+ absorbed in the ascending limb aids in the absorption of H2O 
in the descending limb. After the tubular filtrate passes through the ascending limb of Henle it 
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is hypotonic as it has lost most of its Na+ before it enters the distal convoluted tubule.  
 
The distal convoluted tubule epithelium, the connecting tubule,  and the collecting duct have 
considerably “tighter” epithelial tight junctions to prevent further paracellular ion transport as 
much of the filtered Na+ has been actively reabsorbed. Most of the amiloride-sensitive Na+ 
transport that takes place from the distal convoluted tubule onward is dependent on endocrine 
stimulation by the hormone aldosterone, and this portion of the nephron is known as the 
aldosterone sensitive distal nephron.  Overall, the nephron reabsorbs 99% of the Na+ that is 
filtered at the glomerulus. The proximal tubule absorbs 65% of the filtered load of Na+, the 
loop of Henle absorbs 25%, and the aldosterone sensitive distal nephron can absorb the 
remaining 9%.   
Na+ Absorption in the Nephron 
 
Transport of Na+ in the nephron can be passive, by diffusion, or driven by electrochemical 
gradients. The sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) located in the 
basolateral membrane of all cells in the body, and in the tubular epithelium is responsible for 
creating this gradient. The Na+/K+-ATPase transports three Na+ ions out of the cell, while 
transporting two K+ ions into the cell using the energy donated by adenosine triphosphate 
(ATP). This basolateral pump is present in all of the tubular nephron segments. The difference 
in absorptive capacities of the nephron segments is dictated by the transport proteins located 
on the apical surface of the tubular epithelium. 
 
Absorption of Na+ in the proximal tubule is facilitated by diffusion through the apical 
membrane’s  Na+/H+ exchanger, the Na+/H+ antiport, and various Na+ symports for the 
coupled absorption of amino acids, glucose, K+, and Cl-.  In the ascending limb of the loop of 
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Henle Na+ is absorbed via the (Na+-K+-2Cl- symport, and in the distal convoluted tubule 
approximately 5% of the filtered load of Na+ is absorbed via the Na+-Cl- symport, known as 
the thiazide sensitive co-transporter. In the collecting tubule and the collecting duct Na+ is 
absorbed by the amiloride-sensitive ENaC. The expression of ENaC is under the regulation of 
aldosterone, which can vary depending on the needs of the organism to allow a final urinary 
excretion of 0.5-5% of the filtered load of Na+. This fine tuning of Na+ balance in the 
aldosterone sensitive distal nephron controls blood volume, and thus blood pressure. 
The Renin, Angiotensin, Aldosterone System 
 
The renin, angiotensin, aldosterone system is a hormone system that regulates blood pressure 
by controlling the extracellular fluid volume of the body. The system is activated when there 
is a decrease in renal blood pressure (25,26), or decrease in dietary Na+ (27). These events 
signal the juxtaglomerular apparatus, which is composed of cells from the afferent and 
efferent arterioles, the macula densa cells of the ascending limb of the loop of Henle, and 
juxtaglomerular mesengial cells, to release renin into the blood stream. Renin cleaves 
angiotensinogen released by the liver to produce angiotensin I. Angiotensin I is cleaved to 
form angiotensin II by angiotensin converting enzyme (ACE), which is present mainly in the 
endothelium of the lung but also to some degree in the kidney’s endothelium.  Angiotensin II 
is a pluripotent hypertensive agent capable of stimulating the circulatory system, the 
hypothalamus, and the adrenal glands. Angiotensin II mediated stimulation leads to 
vasoconstriction of the circulatory system, release of epinephrine from the adrenal medulla, 
and stimulation of the adrenal cortex to release aldosterone leading to increased Na+ retention 
by ENaC in the aldosterone sensitive distal nephron.  
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Aldosterone and ENaC 
 
Aldosterone, first known as electrocortin due to its effect on electrolye metabolism (electro-) 
and origins in the adrenal cortex (cortin), was first described in 1954 by Tadeus Reichstein in 
Basel, Switzerland (28). Aldosterone is synthesized in the cortex of the adrenal glands, which 
are located on the superior surface of the kidneys. Aldosterone increases Na+ transport that is 
sensitive to amiloride (29). This amiloride-sensitive transport  has been shown to be mediated 
by ENaC (17), and amiloride-sensitive ENaC transport induced by aldosterone has been 
demonstrated (30). Stimulation of ENaC mediated Na+ transport by aldosterone is known to 
have an early phase, and a late phase. The early aldosterone response occurs within one hour, 
and involves increased ENaC mediated Na+ reabsorption, translation of αENaC protein, and 
translocation of ENaC from the cytoplasm towards the apical plasma membrane (30,31). The 
late aldosterone response is characterized by further increases in Na+ reabsorption and 
translation, with the additional support of α, β, and γ ENaC mRNA transcription (30). 
Aldosterone is also capable of inducing the serum and glucocorticoid regulated kinase (SGK), 
which is capable of increasing ENaC activity (31). SGK increases ENaC activity by inhibiting 
channel retrieval from the cell membrane by phosphorylating neuronal precursor cell-
expressed developmentally down-regulated 4 (Nedd4) (32).The early aldosterone response 
likely invovles SGK which is translated 30 minutes after glucocorticoid stimulation (33), and 
is co-expressed with ENaC in the distal nephron (31). 
 
To determine the contribution of the CD to the aldosterone sensitive distal nephron, Rubera et 
al. generated CD specific αENaC knockout mice, allowing normal expression of  αENaC in 
the DCT, and the CNT (34). The CD specific αENaC knockout mice were able to to maintain 
Na+ and K+ balance, even when challenged by salt restriction, water deprivation, and K+ 
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loading. This suggested that the primary site of ENaC mediated Na+ reabsorption in the 
aldosterone sensitive distal nephron (ASDN) is the CNT and DCT under a normal salt diet 
and Na+ balance. Loffing et al., have shown that ENaC is expressed primarily in the late 
DCT, the CNT, and the CD in the mouse (35,36), and in the CNT and CD of the rabbit (37). 
Taken together, these findings suggest that the late distal convoluted tubule, and the 
connecting tubule are the primary sites of Na+ reabsorption in the ASDN. 
ENaC Structure and Function 
 
ENaC is composed of three homologous subunits α, β, and γ which share 35% AA identity. 
The primary structure of the subunits suggests two putative alpha helical transmembrane 
domains (M1 and M2 respectively), a large hydrophilic extracellular loop of approximately 
50kD, and a short amino and carboxy termini of approximately 10kD. The M1 domains for 
α, β and γ rat ENaC (rENaC) span AA’s 109-131, 50-71, and 54-75 respectively. The  M2 
domains for α, β and γ rENaC span AA’s 587-613, 529-554, and 541-562 respectively (38). 
 
The large extracellular loop contains multiple N-linked glycosylation sites which differ 
between the subunits, with the β ENaC subunit having 12 potential sites whereas the α and γ 
subunits have six and five, respectively (38). Glycosylation status of the subunits do not affect 
channel function in the Xenopus oocyte expression system (38). In addition to glycosylation 
sites, each subunit has large hydrophobic domains of unknown function in the extracellular 
loop directly adjacent to the M1 and M2 domains, termed H1 and H2. The H1 domains for 
α, β and γ rENaC span AA’s 131-163, 71-105, and 75-107, respectively. The H2 domains for 
α, β and γ rENaC span AA’s 559-587, 502-529, and 514-541 respectively. Due to their 
hydropobicity, the H1 and H2 domains may be partially inserted in the membrane and play a 
role in forming the external channel pore. It has also been demonstrated that the pre-M2 
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domains (H2 domains) of α, β and γ rENaC and Xenopus ENaC (xENaC) are directly 
involved in binding the channel inhibitor amiloride (18,39). 
 
It has recently been established that the α and γ mouse ENaC (mENaC) subunits are 
processed from 95kD and 93kD to 65kD and 75kD proteins, respectively by proteases at 
specific sites in the extracellular loop proceding the M1 and H1 domains. These proteolytic 
processing sites were shown to be furin dependent using furin deficient Chinese hamster 
ovary (CHO) cells, and by mutating a furin consensus motif (RXXR) found in the α (R208A, 
R231A) and γ (R143A) mENaC subunits (40). Furin is a known proprotein convertase 
expressed in the golgi and is capable of trafficking to the cell surface. Further analysis 
revealed that furin cleavage of the α subunit excises a 26 AA peptide that was shown to 
inhibit channel activity (41). A subsequent paper showed a similar mechanism occurring in 
the γ ENaC subunit, where a 43 AA peptide had similar but much more potent effect on the 
inhibition of ENaC activity, and required cleavage by furin and prostasin, a cell surface 
expressed serine protease (42). From these studies it was concluded that furin and prostasin 
play an essential role in activating ENaC by exising inhibitory peptides proceding the M1 and 
H1 domains.  
 
Interestingly, low NaCl diet and aldosterone infusion have been shown to simultaneously 
increase insertion of α, β and γ ENaC into the apical membrane of distal nephron epithelial 
cells, and  induce cleavage of the γ subunit from 87kD to 70kD (43). Cleavage of both α and γ 
ENaC was induced by restricted NaCl diet in a more recent study (44). It is important to note 
that these in-vivo studies do not allow the possibility of determining if the cleavage events 
were occurring prior to or proceeding insertion into the apical plasma membrane (activation 
cleavage vs. degredation of internalized channels). However, subunit cleavage under 
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conditions of NaCl restriction or aldosterone infusion correlates with increased ENaC 
function, suggesting a causative role. 
 
The extracellular loop of ENaC also contains highly conserved cysteine rich domains, CRD1 
and CRD2, with 16 conserved cysteine residues in total. Mutation of cysteine 1 in α ENaC 
occurs in patients with pseudohypoaldosteronism type 1 (a disease characterized by severe 
salt wasting), and leads to decreased channel function and Na+ loss (45). Disulfide bonds can 
form between cysteine residues and confer secondary structure essential for proper protein 
assembly into complexes and consequentially proper protein function. After mutation of all 
16 cysteine residues in the α rENaC subunit, it was determined that cysteines 1 and 6 from 
CRD1 in α, β and γ rENaC and cysteines 11 and 12 from CRD2 in α and β rENaC were 
essential for channel function, and normal levels of surface expression in comparison to wild-
type channels (45). The essential cysteines in the extracellular loop of the ENaC subunits are 
thought to form disulfide bonds, thereby maintaining channel structure after cleavage by 
serine proteases. 
 
The cleavage of the extracellular loop of the α and γ ENaC subunits is possibly affected by 
the structural characteristics of the loop.  Glycosylation of the extracellular loops differs 
between the subunits, and could provide protection from proteolytic cleavage. Disulfide 
bonds formed between conserved cysteine residues could also be responsible for maintaining 
channel structure after cleavage of the α and  γ ENaC subunits. The structure of the three 
subunits with glycosylation sites and disulfide bridges is outlined in Figure 3. From this 
figure, it can be visualized that the β ENaC subunit is heavily glycosylated at the protease-
sensitive region proceeding the M1 and H1 domains, possibly protecting it from cleavage, 
whereas the α and  γ ENaC subunits are less well protected by glycosylation. 
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Figure 3: The structure of the α, β, and γ rENaC subunits. The structures include 
transmembrane domains (white boxes), hydrophobic domains (gray boxes), glycosylation 
sites (Y-shaped branches), disulfide bonds between conserved cysteines (dashed lines), and 
furin consensus motifs (arrows).  
 
The amino termini of the three rENaC subunits contains a highly conserved glycine residue (α 
95, β 37, and γ 40). Patients with pseudohypoaldosteronism type 1 (PHA-1) were shown to 
have mutations effecting this conserved glycine residue (46). It was shown that mutating this 
glycine resulted in decreased ENaC open probability, without effecting surface expression 
(47), implicating the amino terminus of the ENaC subunits in channel gating. 
 
The carboxy termini of the three ENaC subunits contains proline-rich regions, which provide 
signals guiding channel localization and degradation via ubiquitination and the proteasome. 
The carboxy terminus of α ENaC contains a proline-rich region referred to as SH3, which has 
been shown to be responsible for its localization of the apical plasma membrane, allegedly 
through cytoskeletal interactions (48). Proline-rich regions in the carboxy termini of α, β and 
αrENaC 
βrENaC 
γrENaC 
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γ ENaC subunits contain PY motifs which are involved in channel turnover, and mutation of 
these motifs increases channel activity (49,50). The PY motifs in the β and γ ENaC subunits 
have been shown to bind to WW domains of Nedd4 implicating this protein in the down-
regulation of ENaC function (49). Liddle’s syndrome is an autosomal dominant form of 
hypertension caused by mutations in these PY motifs in the carboxy termini of the β and 
γ ENaC subunits, again demonstrating the importance of ENaC in blood pressure regulation 
(50).  
 
The α ENaC subunit was also shown to contain a phosphorylation site at AA 621 which was 
shown to be independent of Nedd4, and caused a two to three fold increase in ENaC currents 
(51). The carboxy terminus of the β and γ ENaC subunits can also be phosphorylated, and 
phosphorylation can be increased by insulin, aldosterone, and protein kinases A and C (52).  
 
The tertiary and quaternary structure of ENaC has remained elusive due to the inability to 
express and purify large quantities of the protein required for crystallization. However, the 
primary amino acid sequence contains several motifs that allow structural predictions and 
comparison to other more well defined ion channels. This model of ENaC is widely accepted 
by the academic community. Less well accepted is the stoichiometric ratio between the α, β, 
and γ subunits. A tetrameric architecture was suggested by Firsov et al. in the European 
Journal of Molecular Biology (53), and by Kosari et al. in the Journal of Biological Chemistry 
(54), in the fall of 1998. The formation of a tri- and tetrameric constructs composed of fused 
α, β, and γ subunits by Firsov et al. was used to determine that two α subunits surrounded by 
one β and one γ subunit was the probable configuration. This observation was supported by a 
two fold abundance of α over the β and γ ENaC subunits at the cell surface by antibody 
binding experiments. This was further supported by titrating Zn2+ sensitive vs. wild-type α, β, 
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and γ ENaC subunits which suggested the presence of 2α, 1β, and 1γ using a model similar to 
that of Roderick Mackinnon for determining the stoichiometry of the shaker K+ channel (55).  
 
Kosari et al. also used titration of mutant and wild-type subunits to conclude that a 2α, 1β, 
and 1γ ENaC subunit stoichiometry was involved in functional channel formation. To further 
support the tetrameric architecture of ENaC, Coscoy et al. concluded that the FMRFamide-
activated ion channel (FaNaCh), which is homologous to ENaC and degenerin family of ion 
channels, is tetrameric by subunit cross-linking experiments (56). 
 
In contrast to these results, in the Journal of Biological Chemistry, Snyder et al. suggested an 
alternative stoichiometry of 3α, 3β, and 3γ subunits, based on sucrose gradient sedimentation 
of an ENaC complex of 950kD (57), as well with subunit titration experiments in the style of 
MacKinnon. It is difficult to rationalize how these independent laboratories came up with two 
alternative models for ENaC stoichiometry, when all groups used a similar method of titrating 
blockable subunits. Kosari et al. claimed that if wild-type and blockable α ENaC were 
combined 1:1 and the channel contained 1, 2, or 3 α ENaC subunits the fraction of active 
channels would be 50%, 30%, and 15%, respectively. However, Snyder et al. claim that with 
the same number of α ENaC subunits involved in channel formation the fraction of active 
channels would be 30%, 15%, and 12%, respectively. Therefore, the difference between the 
conclusions in these two papers lies in their mathematical models. 
 
Staruschenko et al. also concluded that ENaC channels formed a 3α, 3β, and 3γ subunit 
complex based on fluorescence resonance energy transfer (FRET) experiments (58). 
However, Staruschenko et al. demonstrated that in their experimental system α ENaC subunit 
alone could form functional channels but αβ and αγ subunits could not. These results are in 
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contrast to personal observations, as well as previously reported observations where currents 
are seen in α2β2 and α2γ2 conditions (17,59), and would disrupt their FRET theory since α2β2 
and α2γ2 channels would display FRET with flourescing β and γ subunits.  
 
Several cation channels with two transmembrane domains including FaNaCh, and the shaker 
K+ channel are thought to form tetramers (55,56), which lends validity to the tetrameric 2α, 
1β, and 1γ model of ENaC.  The mathematical models used in these studies, based on the 
work of Roderick MacKinnon, have subsequently been validated when Long et al. published 
the crystal structure of the shaker K+ channel, revealing a tetrameric architecture (60). 
Unfortunately, without the crystal structure of purified ENaC it cannot be concluded with 
certainty which model is correct, although a tetrameric architecture is probable.  
 
High homology between amphibian and mammalian species (60%) suggests that channel 
divergence from one subunit into three subunits occurred before this taxonomical division (4). 
The retention of functional stablity for over 300 million years demonstrates the importance of 
ENaC in regulating Na+ transport. Several domains have been highly conserved between 
species as well as between the subunits, demonstrating their functional relevance. These 
conserved elements consist of the 30 amino acids preceding the first transmembrane domain, 
the cysteine-rich box, and a region including the second transmembrane domain. The 
conserved structural complexity of ENaC and its different regulatory domains suggest that 
channel activity is very tightly controlled.  
 
Preferential assembly of the ENaC subunits was demonstrated by Canessa et al. (61). It was 
shown that co-expressing the α, β, and γ ENaC subunits in Xenopus oocytes resulted in 
maximal channel activity, whereas expression of α, αβ, αγ ENaC resulted in small but 
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significant currents. A later study by Firsov et al. demonstrated that co-expressing the α, β, 
and γ ENaC subunits in Xenopus oocytes resulted in maximal surface expression, whereas 
expression of α, αβ, αγ ENaC resulted in much lower levels of surface expression, further 
confirming a preferential assembly of the ENaC subunits (62).  
 
ENaC open probability (Po) is highly variable. A study of subunit composition revealed that 
αβ channels remain in a constitutively open position (Po 0.54), whereas αγ channels had a 
highly variable Po between 0.16 and 0.78 (59). Additionally, it has been demonstrated that 
ENaC channels can be present at the cell surface in a “near silent” state with a Po of 0.02, 
which can be elevated to a  Po of 0.54 by treatment with serine protease (63). It is tempting to 
speculate that the range in Po seen in αγ but not αβ channels could be due to proteolytic 
activation of the γ subunit. 
Proteases 
 
Proteases (also known as endopetidases and proteinases) are enzymes that catabolize the 
hydrolysis of peptide bonds linking AA’s together into a polypeptide chain (protein). 
Proteases were one of the first enzyme classes studied extensively, and represent one of the 
largest gene families accounting for 2% of the genes in all organisms (64). The importance of 
proteases is illustrated by the fact that 18% of the sequences in the Swissprot database are 
proteolytically processed (64). Since proteases are capable of cleaving the peptide bonds of 
proteins, and proteins are the building blocks of organisms, it is imperative to control the 
activity of proteases so that they are not constantly digesting proteins in an uncontrolled 
manner. There are two major regulators of protease activity. Firstly, proteases are synthesized 
in an inactive form as proenzymes. The proproteases are activated when they get to their 
target, or appropriate environment in the cell. Secondly, protease inhibitors are synthesized by 
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the cell to inhibit proteases. The blood has long been known to have protease inhibitory 
properties to control the effects of proteases secreted into the bloodstream (65). Protease 
inhibitors will be more thouroughly discussed in the serine protease inhibitor section. 
Serine Proteases 
 
 
Proteases are classified by the chemical mechanism of catalysis, details of the reaction 
catalyzed, and by molecular structure and homology. Perhaps the most useful for 
understanding function is the catalytic classification system which defines serine, cysteine, 
threonine, aspartic, glutamic or metallo catalytic type classes of proteases. The most abundant 
proteases classified by this system are the serine proteases, which account for one third of the 
protease family. Serine proteases are responsible for a wide variety of biological functions in 
mammals such as digestion, coagulation, fibrinolysis, immunity, fertilization, and embryonic 
development. Serine proteases are named after their nucleophilic serine residue located in 
their active site. This active site contains three essential AA’s aspartic acid-histidine-serine 
(D-H-S, or Asp-His-Ser), and is referred to as the “catalytic triad”, due to its positive charge 
which instigates a nucleophilic attack on the peptide bond. The catalytic triad actually consists 
of two diads, one S-H and one H-D. The importance of this triad to biological function has 
been demonstrated by its independent evolution in four separate structural contexts (66). The 
serine protease family can be further divided into the clans chymotrypsin, subtilisin, 
carboxypeptidase Y, and Clp protease. The serine proteases of the chymotrypsin fold are the 
most abundant in nature and account for 240 of the 2000 proteases listed in the MEROPS 
protease database (67).  
 
The proteolytic cleavage by proteases of the chymotrypsin fold involves the transfer of a 
proton from S to H and D of the catalytic triad, making the S a stronger nucleophile (Figure 
- 33 - 
4A). The activated S can then attack the P1-P1’ peptide bond  (Nomenclature for the substrate 
AA’s, Pn,…P2, P1, P1’, P2’, Pn’,  where P1 P1’ represent the peptide bond that is cleaved) 
between AA’s R1 and R2, forming a transient tetrahedral intermediate (Figure 4B). Release of 
the amino terminal peptide (Pn…P1) of the substrate is facilitated by donation of a proton 
from H of the catalytic triad (Figure 4C). H and D then collaborate to react with H2O forming 
a second tetrahedral intermediate with S of the catalytic triad (Figure 4D). The D and H 
residues donate another proton to S allowing breakdown of the tetrahedral intermediate and 
the release of the carboxy terminal peptide (P1’…Pn’) (Figure 4E-F). The donation of protons 
by the AA’s of the catalytic triad which facilitate the proteolytic cleavage represents a relay of 
positive charge, which is the rationale behind its alternative alias “the charge relay sytem.”  
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Figure 4: Proteolytic cleavage by proteases of the chymotrypsin fold. Transfer of a proton 
from S to H and D of the catalytic triad makes S a stronger nucleophile (Figure A). The 
activated S can then attack R1 and R2, forming a tetrahedral intermediate (Figure B). Release 
of the amino terminal peptide of the substrate (Figure C). H and D collaborate to react with 
H2O forming a second tetrahedral intermediate with S (Figure D). The D and H residues 
donate another proton to S allowing breakdown of the tetrahedral intermediate and the release 
A 
B 
C 
D 
E 
F 
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of the carboxy terminal peptide (P1’…Pn’) (Figure E-F). Modified from (68). 
 
All serine proteases of the chymotrypsin fold share a common structure of two β barrels with 
the catalytic triad at the interface of these two domains. This fold contains important enzyme-
substrate interaction points where hydrogen bond formation between the enzyme with  P1 and 
P3 orients the scissile peptide bond with the catalytic S-H for nucleophilic attack and 
subsequent cleavage (69).   
 
Trypsin, chymotrypsin, and elastase are serine proteases of the chymotrypsin fold. What 
separates the proteolytic activity of these enzymes is their peptide target specificity. The AA’s 
of the protease that come in direct contact with the target peptide substrate in the binding 
pocket determine the specificity of the protease for the substrate (Figure 5). Trypsin has a 
deep pocket with a negatively charged D at its base conferring preferential cleavage of 
positively charged AA’s such as lysine (K) and arginine (R) (70). Chymotrypsin has a similar 
pocket but without the D which gives it specificity for large aromatic residues phenylalanine 
(F), tyrosine (Y), and tryptophan (W) (71). Elastase has a more shallow pocket that is more 
hydrophobic due to AA’s 216 and 226 at the opening of the pocket, which are glycine’s (G) 
for trypsin and chymotrypsin, but are valine (V) and threonine (T) for elastase, which restrict 
the substrate specificity of elastase to small hydrophobic amino acids alanine (A), V, and S 
(72).   
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Figure 5: Binding pockets of trypsin, chymotrypsin, and elastase. Substrate specificity is 
dictated by AA’s lining the binding pocket. Conserved AA’s at the opening and base of the 
pocket differ between these proteases and confer specificity. A negative charge at the base of 
the trypsin binding pocket confers specificity for positively charged AA’s R and K. A similar 
pocket is present in chymotrypsin and confers specificity for F, Y, and W. Elastase has bulky 
valine and threonine residues at the opening of its binding pocket giving it a specificity for 
small unbranched AA’s A, V, and S. Modified from (73). 
 
It has been demonstrated that the extracellular loop of the α and γ ENaC subunits contain a 
furin consensus motif (RXXR), as previously mentioned. Furin is a known serine protease of 
the subtilisin clan. However there are several serine proteases of the subtilisin clan that can 
cleave at the RXXR consensus motif such as, PC1/3, PC2, PACE4, PC4, PC5/6, and PC7 
(74). Collectively this group is referred to as the proprotein convertases, and is involved in 
processing growth factors, proteases, and receptors.  
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Serine Protease Inhibitors 
 
Protease inhibitors are essential for controlling the cleavage of proteins by proteases. The 
protease inhibitory properties of blood (65), are due to the presence of α1-antitrypsin. The 
destructive nature of proteases and the importance of protease inhibitors is illustrated by α1-
antitrypsin deficiency, where a mutation in this protease inhibitor gene results in severe 
proteolytic overactivity, which digests lung tissue (75,76). Serine protease inhibitors are the 
most abundant family of protease inhibitors. Three different types of serine protease inhibitors 
can be classified by their mechanism of action: canonical (standard mechanism) and non-
canonical inhibitors, and serpins (77). Canonical inhibitors (such as aprotinin) bind to the 
enzyme through an exposed convex binding loop, complementary to the active site of the 
enzyme. The non-canonical inhibitors interact through their N-terminal segment. Serpins, 
similarly to the canonical inhibitors, interact with their target proteases in a substrate-like 
manner. Cleavage of a single peptide bond in the binding loop of a serpin leads to dramatic 
structural changes. This suicide substrate mechanism involves a large conformational change 
in the serpin, which traps the target protease. Serpins form a covalent bond with the serine 
residue of the catalytic triad of serine proteases (78).  
Serine Proteases and ENaC 
 
A novel role for serine proteases was demonstrated when channel activating protease 1 
(CAP1), was shown to be capable of increasing ENaC activity (79). It was also demonstrated 
that aprotinin, a serine protease inhibitor could decrease ENaC activity in a kidney cell line 
(A6 cells). Trypsin added to the apical medium of these cells was capable of recovering ENaC 
transport blocked by aprotinin, further indicating serine proteases in the regulation of Na+ 
transport. Vuagniaux et al., have shown that CAP1 is co-expressed with ENaC in the cortical 
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collecting duct (CCD), and the DCT (80). Consequently, CAP1 homologs CAP2 and CAP3 as 
well as other serine proteases have been demonstrated in-vitro and in-vivo to increase ENaC 
mediated INa in multiple cell types including collecting duct and lung epithelial cells (63,80-
90).  
 
Improvements in the detection of ENaC protein expression using polyclonal and monoclonal 
antibodies, as well as by using tagged subunits have revealed that the αENaC and γENaC 
subunits have multiple molecular weight bands in western blots. Hughey et al., have shown 
that these bands are cleavage products created upon co-expression of all three (α,β,γ) of the 
mENaC subunits in CHO and Mandin-Darby kidney cells (MDCK) cells heterologous 
expression systems (91). It was also demonstrated that ENaC contains consensus motifs for 
the serine protease furin. Mutation of the furin consensus motif in α and γ mENaC subunits 
prevented the formation of the cleavage products in MDCK, CHO cells and Xenopus oocytes 
(40). However, the serine protease prostasin (the human homologue of CAP1) has been 
shown to have a consensus sequence (R/K-H/R/K-X-R-X-X-X-S/A) extremely similar to 
furin (R-X-X-R) (92), suggesting that furin is not necessarily the  protease that is cleaving 
ENaC in-vivo. Aprotinin can drastically decrease ENaC activity, but is not capable of 
inhibiting furin (93), suggesting that furin is not solely responsible for the activation of ENaC, 
if at all. Furthermore, α and γ mENaC furin mutants were still capable of being activated by 
trypsin to wild-type INa levels (40), suggesting that furin cleavage is not related to channel 
activation by serine proteases, but may be involved in channel processing. There is also 
evidence that cleavage of the γ ENaC subunit in-vivo results in an alternative cleavage that 
appears to be more distal from the N-terminus than the reported “furin cleavage site” (43,44). 
This cleavage in-vivo results in a fragment less than 70kD, whereas the furin cleavage site 
demonstrated in cell lines and in the Xenopus oocyte results in a fragment of 75-76kD. 
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Therefore, the mechanism of ENaC activation by serine proteases is unknown. What is 
consistant between the in-vivo and in-vitro experiments is that ENaC is activated by serine 
proteases, and the γ subunit is proteolytically cleaved. 
 
Questions to be answered 
 
The purpose of this work was to determine the precise role of the previously described ENaC 
cleavage events, and to determine if ENaC was indeed the substrate for serine proteases 
capable of increasing ENaC activity. 
 
Despite rapid progress in the understanding of the stimulation of ENaC by serine proteases, 
several key questions remain unanswered. Firstly, what is the mechanism of ENaC activation 
by proteases? The answer to this question is likely to be found by determining the substrate 
that is cleaved by serine proteases, which increases ENaC activity. Secondly, can the 
stimulation of ENaC by serine proteases play a physiologic or pathophysiologic role in-vivo? 
Previous studies suggest that proteases are co-expressed in ENaC epithelia such as the lung, 
kidney, and colon, and endogenous stimulation of ENaC can be inhibited by protease 
inhibitors. This could potentially provide a mechanism to control inappropriate activation of 
ENaC in disease states characterized by overexpression of serine proteases. Thirdly, what is 
the nature of endogenously expressed protease and protease inhibitor genes in the distal 
nephron? Can cells expressing ENaC modulate its activity by altering the expression of 
proteases and protease inhibitors? 
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Working Hypothesis 
 
The working hypothesis assumes that ENaC is expressed at the cell membrane or in a sub-
apical protein pool as an uncleaved proprotein, ready to be cleaved by external or cell surface 
expressed proteases. In this situation ENaC is closed and Na+ transport is blocked. It is 
proposed that protease inhibitors are present in-vivo and capable of maintaining ENaC in the 
closed configuration.  Following this logic, in disease states where the protease – protease 
inhibitor balance is altered, modulation of ENaC transport can occur. It is not clear wether 
cleavage of the channel takes place prior to or after insertion of the complex in the cell 
membrane. To address this issue we used biotinylation and the preferential assembly of ENaC 
in the Xenopus oocyte.  
 
Specific Aims 
 
Aim 1: Determine if cleavage of ENaC is occuring intracellularly, upon degradation, or at the 
cell surface. If cleavage is occuring, which subunits are affected? 
 
Aim 2: Determine if ENaC cleavage can be involved in disease states such as cystic fibrosis 
(CF), where elevated protease concentrations could lead to increased ENaC activity. 
 
Aim 3: Determine if protease inhibitor genes are capable of regulating ENaC function as 
antagonists to proteolytic activation. 
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Experimental Procedures 
Complementary RNA (cRNA)  
 
Complementary RNAs of rat αβγ ENaC subunits, serpinH1, ROMK, and human prostasin 
were synthesized in vitro, using SP6 and T7 RNA polymerase. C-terminus V5 epitope 
tagged  α, β and γ ENaC subunits were created by PCR amplification. For each subunit, 
two primers were synthesized. The forward primer contains the SpeI site and the start 
codon of the ENaC gene; the reverse primer contains the NotI site, the coding sequence for 
V5 and the C-terminal sequence of the ENaC gene. PCR products were purified and cloned 
into the SpeI/NotI sites of pSD5 vector. The cRNAs were injected into Xenopus oocytes (3 
ng of total cRNA/oocyte) and injected oocytes were kept in modified Barth solution 
(MBS) containing 88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.8 mM MgSO4, 0.3 mM 
Ca(NO3)2, 0.4 mM CaCl2, 10 mM Hepes-NaOH (pH 7.2). Electrophysiological 
measurements and cell surface biotinylation were performed 24 hours after injection. 
Amiloride-sensitive Na+ current (INa) was recorded using the two-electrode voltage clamp, 
and was defined as the difference between current obtained in the presence (5 μM) and in 
the absence of amiloride. 
 
Two electrode voltage clamp 
 
Two electrode voltage clamp was used to determine whole cell ENaC activity in Xenopus 
oocytes injected with α, β, and γ rENaC cRNA. A voltage clamp generates current with two 
electrodes. Transmembrane voltage was determined with a voltage electrode, and a current 
electrode injected current into the cell. Holding voltage was set at -100mV, favoring the entry 
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of Na+ into the oocyte through ENaC, the voltage clamp maintained the cell at this voltage. 
The voltage and current electrodes were connected to an amplifier, which measured 
membrane potential and fed the signal into a feedback amplifier. The feedback amplifier also 
received an input from the signal generator that determined the holding voltage, which 
subtracted the membrane potential from the holding potential (-100mV), magnified the 
difference, and sent an output to the current electrode. Whenever the cell deviated from the 
holding voltage, the operational amplifier generated the difference between the holding 
potential and the actual voltage of the cell. Thus, the clamp produced a current equal and 
opposite to the ionic current giving an accurate reproduction of the currents flowing across the 
membrane of the oocyte. During two electrode voltage clamp, oocytes were continually 
perfused with 120mM Na+ frog ringer solution which contained 120mM NaCl, 2.5mM KCl, 
1.8mM CaCl2, 10mM HEPES, at pH 7.2.  
 
Two electrode voltage clamp was also used to determine whole cell ROMK activity in 
Xenopus oocytes injected with ROMK cRNA. Holding voltage was set at -100mV favoring 
the entry of K+ into the oocyte through ROMK. Oocytes were bathed in 5 mM KCl, 110mM 
NaCl, 1 mM MgCl2, 1mM CaCl2, and 5mM Hepes, pH 7.4. ROMK currents were defined as 
the difference between current obtained in the presence (2mM) and absence of barium-
acetate. 
 
Incubation of Xenopus oocytes with proteases and inhibitors 
 
ENaC cRNA injected oocytes were incubated for 5 minutes at room temperature in MBS 
solution containing proteases, and/or inhibitors. Elastase from human neutrophils (Serva 
Electrophoresis) was used at a concentration of 100μg/ml, trypsin (Sigma) was used at a 
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concentration of 10μg/ml, aprotinin (Sigma) was used at a concentration of 100μg/ml and 
engineered human elastase inhibitor (Debiopharm S.A.) was used at a concentration of 
44μg/ml. 
  
Biotinylation of ENaC subunits on the cell surface 
 
 
Biotinylation was performed in 40 well plates, using 50 oocytes per experimental 
condition. All biotinylation steps were performed at 4˚C to minimize internalization of 
biotinylated surface expressed proteins. After incubation in MBS solution for 30 min at 
4˚C, the oocytes were washed three times with MBS. After the last wash, the MBS solution 
was removed and replaced by a biotinylation buffer containing 10 mM triethanolamine, 
150 mM NaCl, 2 mM CaCl2, 1 mg/ml EZ-link sulfo-NHS-SS-Biotin® (Pierce), pH 9,5. 
This buffer maximized the ability of biotin to bind to the amino groups of lysine residues 
in cell surface expressed proteins. A pH of 9.5 was high enough to partially de-protonate 
the amino group of lysine (pKa=10.5) allowing efficient biotinylation, but not high enough 
to compromise the cell membrane of the oocyte. The incubation lasted 15 min with gentle 
agitation. The biotinylation reaction was stopped by washing the oocytes twice with 
Quench buffer containing 192 mM glycine, 25 mM Tris-Cl (pH 7,5), added to MBS 
solution. The amino group of glycine, present in the buffer quenched the further 
biotinylation of proteins, since glycine was present in excess of biotin. Additionally, the 
pH was reduced to a more physiologic level where lysines would be protonated and no 
longer susceptible to biotinylation. After the second wash, oocytes were incubated for 5 
min in the Quench buffer with gentle agitation. Oocytes were then washed twice with MBS 
solution, then lysed by repeated pipetting with Pasteur pipettes in Lysis buffer (20 
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μl/oocyte) containing 1% Triton X-100, 500 mM NaCl, 5 mM EDTA, 50 mM Tris-Cl, and 
5mg/ml each of leupeptin, antipain, and pepstatin. The lysates were vortexed for 30 sec 
and centrifuged for 10 min at ∼10 000g. Supernatants were transferred to 1.5 ml Eppendorf 
tubes containing 50 μl immunopure immobilized streptavidin beads (Pierce) and washed 
with lysis buffer to remove Na+ azide. Strepatividin has a very strong affinity for biotin, 
and therefore the streptavidin beads bound to biotin, which was bound to the surface 
expressed proteins. After overnight incubation at 4˚C with agitation, the tubes were 
centrifuged for 1 min at 5 000 rpm. Supernatant (non-biotinylated pool) was removed and 
the streptavidin beads bound to biotinylated surface proteins were washed three times with 
Lysis buffer. Then, 35 μl of 2x sample buffer (for SDS-PAGE) was added to the beads. All 
samples were heated for 5 min at 95°C before loading on the 8-15% SDS-PAGE. The cell 
surface labeling was restricted to plasma membrane proteins, as shown by the absence of 
any significant amount of actin in this fraction. The non-biotinylated protein pool 
represents essentially proteins expressed intracellularly (i.e. intracellular pool of 
membrane- and non membrane- associated proteins) and is characterized by a large amount 
of actin. 
 
Western blotting 
 
Proteins were migrated on a 8-13% gradient of sodium dodecyl sulfate (SDS an anionic 
detergent) polyacrylamide gel, and electrophoresed (PAGE) with a current of 30μA per 
15cm by 15cm by 0.1cm gel. Proteins were heated to 95oC for five minutes in the presence 
of SDS and β-mercaptoethanol, to denature the protein and reduce disulfide bonds.  SDS 
coated the proteins with negative charge so that they could be migrated through the electric 
field with a uniform mass to charge ratio, and seperated in the polyacrylamide by 
- 45 - 
molecular mass. A mixture of synthetic proteins of known molecular mass was also added 
to the gel, and used as a reference of molecular mass.  
 
Proteins were then transferred to a nitrocellulose membrane by applying a voltage of 
40mV for approximately 16h (overnight). The nitrocellulose membranes were stained with 
ponceau rouge to visualize the molecular mass markers and ensure that proteins were 
efficiently transferred, and that there was equal protein loading between experimental 
groups. Membranes were rinsed with tris-buffered saline (TBS) -tween, and blocked with 
TBS with powdered milk and nonidet-P40 (NP-40) to prevent non-specific binding of 
antibodies. Antibodies were incubated with the membrane in the presence of TBS 
powdered milk. Secondary antibodies linked with horseradish peroxidase (GE healthcare) 
which flouresced in the presence of chemiluminescent reagent (Supersignal®, Pierce), 
were used to visualize proteins of interest. Antibody labelled proteins were then visualized 
by exposure to light sensitive film and developed. Western blots were quantified using 
BIO-RAD laboratories Quantity One® image quantification software.  
 
Antibodies  
 
Monoclonal anti-V5 antibody was obtained from InVitrogen and used according to the 
manufacturer’s instruction at a dilution of 1:1000, with a secondary mouse antibody at a 
dilution of 1:10 000. The actin antibody was from Sigma, and used at a concentration of 
1:5000, with a secondary rabbit antibody at a concentration of 1:10 000.   
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Statistical Analysis 
 
All data represented as means and standard error of the mean, as indicated by the bars. 
Statistical significance was determined by Students t-test when testing one group against 
another group. When testing multiple groups simultaneously, statistical significance was 
deterined by analysis of variance (ANOVA) and, when appropriate, it was followed by 
Bonferroni post-test. A p value less than 0.05 was considered statistically significant. The 
number of independent experimental repetitions is represented by n. Statistics were 
calculated using Graphpad Prism® software. 
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RESULTS 
Preferential assembly of α, β and γ ENaC subunits in Xenopus 
oocyte: endogenous proteolysis of  γ subunit occurs at the cell 
surface and correlates with ENaC mediated sodium transport 
Aim 1 
Determine if cleavage of ENaC is occuring intracellularly, upon degradation, or at the cell 
surface. If cleavage is occuring, which subunits are affected? The oocyte expression system is 
useful for precise correlation of cell surface expression and ENaC function.  In this system, 
one can measure macroscopic currents (INa) and correlate them with molecular species of 
ENaC expressed at the surface by biotinylation labeling. It is then possible to correlate 
cleavage of ENaC at the cell surface and channel function. The limitation of the system is that 
the oocyte is not organized as an epithelial sheet, therefore significant differences in 
trafficking and cell surface expression may be expected to be dependent on the tissue and cell 
specific intracellular milieu.  
 
INTRODUCTION 
It has been established that co-expression of all three ENaC subunits results in the cleavage of 
the αENaC and γENaC subunits (91), without the addition of extracellular proteases. In ENaC 
transfected MDCK cells, α ENaC and γ ENaC subunits are expressed at the cell surface as full 
length and cleaved forms (94), suggesting that intracellular cleavage is not necessary for cell 
surface expression. In addition, it has been demonstrated that there are surface expressed 
ENaC molecules known as “near silent channels”, that exhibit minimal Na+ transport until 
they are activated by externally applied proteases (63,89). 
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In the rat kidney, appearance of a second molecular weight species of γ ENaC has been 
observed in conditions associated with increased ENaC function : following 10 days of salt 
restriction (43), 10 days of aldosterone infusion (43), or 7 days of water loading (95). Loffing 
et al. have demonstrated that increased aldosterone levels caused by low salt diet are 
associated with an increase in α ENaC expression, and a shift of ENaC location in the DCT 
and CNT from the cytoplasm to the apical membrane, reflecting the increase in channel 
activity (31,36). Expression of the α ENaC subunit is known to be necessary for insertion of 
the ENaC complex into the apical membrane, and functional activity (62). We wished to take 
advantage of the preferential assembly of the ENaC, to study the cleavage of the ENaC 
subunits at the cell membrane. The assembly hypothesis suggests that channel insertion into 
the cell membrane occurs upon co-expression of the α, β  and γ ENaC subunits and results in 
maximal insertion of the channel into the cell membrane and maximal channel activity. Using 
this model, cleavage should occur preferentially when all the subunits are co-expressed. 
Injecting individual subunits cRNAs should not result in cleavage, and injection of αβ, αγ, or 
βγ subunit combinations should result in minimal cleavage since these channels demonstrate 
lower functional activity than αβγ channels. 
 
HYPOTHESIS 
 
We wish to study the cleavage of ENaC, to determine if this cleavage occurs prior to or after 
insertion of the channel complex into the cell membrane. Specifically we hypothesized : 
1. Proteolytic cleavage of α and γ ENaC is not necessary for surface expression, the α and γ 
subunits of αβγ channels are cleaved resulting in increased activity over αβ and αγ 
channels.  
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2. Activation of ENaC by serine proteases applied extracellularly causes further cleavage 
and activation of surface expressed α and γ ENaC molecules. 
 
RESULTS 
 
The following 16 pages contain an article submitted for publication April 4, 2007 in the 
Journal of Biological Chemistry. Your doctoral candidate has preformed almost all aspects of 
these experiments including cRNA synthesis, cRNA microinjection into Xenopus oocytes, 
measurement of INa by TEV, cell surface biotinylation, SDS-PAGE, Western blotting, and 
blot analysis by densitometry. Nicole Fowler-Jaeger who also performed cRNA 
microinjection, and measurement of INa by TEV provided technical assistance. Nicole Fowler-
Jaeger performed extraction of oocytes from Xenopus laevis. The plasmids containing 
α, β, and γ ENaC subunits tagged with V5 at the carboxy terminus was a gift from M. Jackson 
Stutts (University of North Carolina, Chapel Hill, U.S.A.). Your author and Bernard Rossier 
wrote the manuscript. Your author, Bernard Rossier, Dmitri Firsov, M. Jackson Stutts, Jean-
Daniel Horisberger, Birgitte Monster-Christensen, and Nicole Skarda edited the manuscript. 
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CELL SURFACE AND CORRELATES WITH ENaC MEDIATED SODIUM 
TRANSPORT 
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The epithelial sodium channel is composed of homologous α, β and γ subunits.  ENaC 
expressed in Xenopus oocytes is preferentially and rapidly assembled into heteromeric αβγ 
complexes. Expression of homomeric α or heteromeric αβ and αγ complexes led to channel 
expression at the cell surface with low activities. Recent studies have demonstrated that α and 
γ ENaC (but not β) subunits undergo proteolytic cleavage by endogenous proteases (i.e. furin) 
correlating with increased channel activity. We reasoned that if cleavage is required for 
channel activation at the cell surface, a precursor-product relationship should exist. We 
therefore assayed the full length subunit and its cleaved product at the cell surface, as well as 
in the intracellular pool for all homo- and heteromeric combinations 
(α, β, γ, βγ, αβ, αγ, βγ and αβγ) and measured the corresponding channel activities as 
amiloride-sensitive sodium transport INa. We show that: i) β subunit alone is not transported 
to the cell surface nor cleaved upon assembly with α and/or γ subunit; ii) α subunit alone (or 
in combination with  β and/or γ) is  efficiently transported to the cell surface, but no 
significant correlation between cleavage and channel activation is observed; iii)  γ subunit 
alone is not transported to the cell surface, but is mainly identified as a full length (87Kd) 
species when assembled into αγ complexes, or as a cleaved 76kDa species in  αβγ complexes, 
corresponding to 20 fold increase in ENaC activity.  Our findings are consistent with a causal 
relationship between γ cleavage at the cell surface and channel activation.  
 
INRODUCTION 
 
The highly sodium selective epithelial 
sodium channel (ENaC) is composed of 
three homologous subunits (α,β,γ) and is 
expressed in several ion transporting 
epithelia, including the kidney, colon, and 
lung (1).  The membrane topology of each 
subunit predicts the presence of two 
transmembrane domains with short 
cytoplasmic amino- and carboxy- termini 
and a large extracellular loop.  ENaC has 
been proposed to be a heterotetrameric 
protein (αβαγ) (2), but octameric or 
nonameric structures have also been 
suggested (3-5). In the Xenopus oocyte 
expression system, it has been possible to 
quantitate the number of channel molecules 
expressed at the cell surface and to measure 
in the same oocyte the amiloride-sensitive 
current generated by the expression of 
ENaC at the membrane (6,7).  This assay 
demonstrated the preferential assembly of 
α2β,γ channels. Maximal ENaC activity 
measured by the amiloride-sensitive inward 
current (INa) is observed only when  α, β, γ  
subunits are co-injected in the Xenopus 
oocyte expression system.  There is an 
excellent correlation between INa and  the 
number (N) of channel molecules expressed 
at the cell surface (6).  When α subunit is 
injected alone (presumably α4 tetramers), 
only 1 or 2% of maximal activity is 
observed.  When αβ  or  αγ  subunits are 
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co-injected (presumably as α2β2 or 
α2γ2, respectively), 5 to 15% of maximal 
activity is recorded.  β or γ subunit alone 
does not lead to any significant channel 
activity, whereas expression of βγ 
(presumably as β2γ2) channels lead to a 
very small activity (2%) and after a 
prolonged incubation (6 to 7 days after 
injection) (8). This data indicated that the α 
subunit has a specific chaperone role, 
bringing the β and γ subunits to the plasma 
membrane, but the β and γ subunits are also 
required to bring α subunits at the cell 
surface. 
The endogenous processing of 
ENaC in the Xenopus oocyte expression 
system is significant and specific for each 
subunit. Hughey et al. (9)  showed that 
when tagged subunits were expressed alone 
in both Chinese hamster ovary or Madin-
Darby canine kidney type 1 epithelial α-
(95kDa), β-(96kDa), and γ-subunits 
(93kDa), each produced a single band on 
SDS gels by immunoblotting. However, co-
expression of αβγ ENaC subunits revealed 
a second band for each subunit (65kDa for 
α, 110kDa for β, and 75kDa for γ). The 
smaller size of the processed α- and γ-
subunits was consistent with proteolytic 
cleavage. Hughey, et al. have subsequently 
implicated furin in ENaC proteolytic 
processing (10). They demonstrated that the 
α and γ ENaC subunits are cleaved during 
maturation at consensus sites for furin 
cleavage. Using site-specific mutagenesis 
of channel subunits, ENaC expression in 
furin-deficient cells, and furin-specific 
inhibitors, the authors proposed that ENaC 
cleavage correlated with channel activity 
(10). A demonstration of a direct 
correlation between endogenous proteolytic 
cleavage of surface expressed ENaC and 
activation in the same expression system 
was not provided. Important questions 
remain : Does the processing occur on the 
exocytic and/or endocytic pathway or at the 
plasma membrane ? What is the relative 
importance of α vs γ cleavage for channel 
activation ? We recently designed an 
experimental protocol which allows 
labelling of cell surface expressed protein 
(11), allowing direct correlation of channel 
cleavage and amiloride-sensitive ENaC 
mediated sodium transport (12). However, 
since both α and γ subunit undergo 
endogenous proteolysis leading to a specific 
pattern for each subunit expressed at the 
cell surface, it is not clear whether α and/or 
γ processing was required for channel 
activation under baseline conditions.  We 
reasoned that if ENaC α and/or γ cleavage 
takes place at the plasma membrane 
causing its activation, there should be a 
precursor-product relationship between the 
pool of full length uncleaved channel 
(precursor associated with little or no ENaC 
activity) and the pool of cleaved channel 
(product associated with increased ENaC 
activity).  We co-injected α, β and γ 
subunits in all combinations and measured 
INa and the size of channel subunit 
expressed at the cell surface (biotinylated 
proteins) or in the intracellular pool (non 
biotinylated proteins) to establish a direct 
correlation between cell surface expression 
of cleaved subunit and sodium transport. 
 
EXPERIMENTAL PROCEDURES 
 
cRNAs. Complementary RNAs of rat αβγ 
ENaC subunits were synthesized in vitro, 
using SP6 and T7 RNA polymerase. C-
terminus V5 epitope tagged  α, β  and γ 
ENaC subunits were created by PCR 
amplification. For each subunit, two 
primers were synthesized. The forward 
primer contains the SpeI site and the start 
codon of the ENaC gene; the reverse primer 
contains the NotI site, the coding sequence 
for V5 and the C-terminal sequence of the 
ENaC gene. PCR products were purified 
and cloned into the SpeI/NotI sites of pSDE 
vector. 
Antibodies. Monoclonal anti-V5 
antibody was obtained from InVitrogen and 
used according to the manufacturer’s 
instruction. The actin antibody was from 
Sigma.   
Expression of ENaC cRNA in Xenopus 
oocytes. The cRNAs were injected 
into Xenopus oocytes (3.3 ng of each 
subunit) and kept in modified Barth 
solution (MBS) containing 88 mM NaCl, 1 
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mM KCl, 2.4 mM NaHCO3, 0.8 mM 
MgSO4, 0.3 mM Ca(NO3)2, 0.4 mM CaCl2, 
10 mM Hepes-NaOH (pH 7.2). 
Electrophysiological measurements and cell 
surface biotinylation were performed 24 
hours after injection. Amiloride-sensitive 
Na+ current (INa) was recorded, using the 
two-electrode voltage clamp and was 
defined as the difference between Na+ 
current obtained in the presence and in the 
absence of amiloride (5 μM). 
Biotinylation of ENaC subunits on the cell 
surface.   Biotinylation was 
performed in 40 well plates, using 50 
oocytes per experimental condition, as 
described (11). All biotinylation steps were 
performed at 4˚C. After incubation in MBS 
solution for 30 min at 4˚C, the oocytes were 
washed three times with MBS. After the 
last wash, the MBS solution was removed 
and replaced by a biotinylation buffer 
containing 10 mM triethanolamine, 150 
mM NaCl, 2 mM CaCl2, 1 mg/ml EZ-link 
sulfo-NHS-SS-Biotin (Pierce), pH 9,5. The 
incubation lasted 15 min with gentle 
agitation. The biotinylation reaction was 
stopped by washing the oocytes two times 
with Quench buffer containing 192 mM 
glycine, 25 mM Tris-Cl (pH 7,5), added to 
MBS solution. After the second wash, 
oocytes were incubated for 5 min in the 
Quench buffer with gentle agitation. 
Oocytes were then washed two times with 
MBS solution, then lysed by repeated 
pipetting with Pasteur pipettes in Lysis 
buffer containing  1% Triton X-100, 500 
mM NaCl, 5 mM EDTA, 50 mM Tris-Cl, 
5mg/ml each of leupeptin, antipain, and 
pepstatin, (20 ml/oocyte). The lysates were 
vortexed for 30 sec and centrifuged for 10 
min at ∼10,000g. Supernatants were 
transferred to the new 1.5 ml Eppendorf 
tubes containing 50 μl immunopure 
immobilized streptavidin beads (Pierce) 
washed with Lysis buffer. After overnight 
incubation at 4˚C with agitation, the tubes 
were centrifuged for 1 min at 5’000 rpm. 
Supernatant (non biotinylated pool) was 
removed and beads were washed three 
times with Lysis buffer. 35 μl of 2x SDS-
PAGE sample buffer was added to the 
beads. All samples were heated for 5 min at 
95°C before loading on the 8-15% SDS-
PAGE. The cell surface labeling was 
restricted to plasma membrane proteins, as 
shown by the absence of any significant 
amount of actin in this fraction. The non 
biotinylated protein pool represents 
essentially proteins expressed 
intracellularly (i.e. intracellular pool of 
membrane- and non membrane- associated 
proteins) and is characterized by a large 
amount of actin. 
Statistical Analysis. All data are 
represented as means and bars indicate 
standard error of the mean. Statistical 
significance was determined by analysis of 
variance (ANOVA) and, when appropriate, 
it was followed by Bonferroni post-test. A p 
value less than 0.05 was considered 
statistically significant. The number of 
independent experimental repetitions is 
represented by n. 
 
RESULTS 
 
Preferential assembly of ENaC 
subunits:  evidence for endogenous and 
selective processing of ENaC subunit.  
α subunit 
After a 24 hour incubation (Figure 
1, panel A),  α subunit alone (lane 1) did 
not generate a significant amiloride-
sensitive current. Co-expression of α with β 
(lane 2) or γ (lane 3) increased INa with 
respect to non-injected oocytes (lane 5), 
representing 5 to 10% of maximal activity 
observed when αβγ subunits were co-
injected (lane 4). A full length uncleaved 95 
kD α subunit band was predominantly 
observed at the cell surface (panel B) of α 
(lane 1),  αγ ( lane 2), αβ (lane 3) and αβγ 
(lane 4) injected oocytes.  Smaller 
fragments (80kD and 65kD) were observed 
but in small proportions (see quantitation, 
Figure 2).  In the non-biotinylated protein  
pool (panel C), the 95kDa band was 
predominantly observed (lanes 1 to 4), 
whereas small but significant amounts of 
80kDa and 65Kd fragments were observed, 
but were not correlated with assembly.  
Quantitation of 3 independent experiments 
is shown in Figure 2. Upon preferential 
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assembly of αβγ complexes, there was a 
small non significant 1.5 – 2 fold increase 
in cell surface expression of α subunit, but 
no significant changes in the amount of 
cleaved fragments. The intracellular pool 
showed that 5 to 10% of the α subunit was 
cleaved as 80kDa/65KDa fragments 
without significant changes upon assembly 
into αγ, αβ or αβγ complexes. 
β subunit 
After a 24 hour incubation (Figure 
3, panel A), β alone (lane 1) or βγ (lane 3) 
subunits together did not generate a 
significant current, whereas αβ (lane 2) or 
αβγ (lane 4) significantly increased INa, 
with respect to non injected oocytes (lane 
5). At the cell surface (Panel B)  a single 
Mr species 105 kD β was detected  in 
αβγ injected oocytes (lane 4) and in small 
proportion in αβ  injected oocytes, with no 
evidence of cleavage or processing. In the 
non-biotinylated protein pool (panel C), a 
single Mr species (105 kD) of β subunit 
was detected in all conditions (lane 1 to 4), 
with no evidence of cleavage or processing.  
We conclude that the β subunit cannot 
traffic to the plasma membrane unless 
accompanied by the α subunit and does not 
undergo any processing during assembly, 
maturation or expression at the cell surface. 
Quantitation of 3 experiments is shown in 
Figure 4. The amount of β subunits 
detected at the cell surface  in β, αβ or βγ 
injected oocytes was small and not 
significantly different from background 
(non injected oocytes), whereas the amount 
of β subunit detected in αβγ injected 
oocytes was significant compared to 
controls. There was no significant 
differences in the amount of β subunits 
detected in the non biotinylated protein 
(intracellular) pool. 
γ subunit 
After a 24 hour incubation (Figure 
5, panel A), γ subunit expressed alone (lane 
1) or βγ subunits (lane 3) did not generate 
any significant amiloride-sensitive current, 
whereas γ co-expressed with α (lane 2) 
yielded around 5% of maximal activity 
observed when αβγ subunits were co-
injected (lane 4). At the cell surface (panel 
B), a 76kD γ subunit species was 
predominantly observed in αβγ injected 
oocytes with a small amount of full length 
(87kD) species observed in some 
experiments.  In the non-biotinylated 
protein pool (panel C), the 87kD full length 
species was predominantly observed (lanes 
1 to 4) with very little, if any, evidence of 
the 76kD species. Quantitation of 3 
independent experiments is shown in 
Figure 6. Upon preferential assembly 
of αβγ complexes, there was a 6 fold 
decrease (p<0.05) in cell surface expression 
of full length 87kD γ subunit, compared to 
αγ injected oocytes. This correlated with a 
10 fold increase (p<0.001) in the expression 
of the cleaved 76kD species in fully 
assembled αβγ channels. This also 
correlated with a 2 fold decrease (p<0.05) 
of the 87Kd species in the non biotinylated 
(intracellular) protein pool, suggesting a 
precursor-product relationship between 
intracellular and cell surface expressed 
channels.  
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DISCUSSION 
 
Preferential assembly of ENaC 
subunits:  evidence for endogenous and 
selective processing of γ ENaC subunit at 
the cell surface which correlates with ENaC 
activation 
The main finding of this study is 
that the γ subunit undergoes proteolytic 
cleavage at the cell surface only when co-
injected with αβ subunits. There was a 
striking correlation between γ cleavage and 
ENaC activation, suggesting a causal 
relationship (Figure 7). The endogenous 
protease responsible for the γ cleavage is 
not known. A likely candidate is furin or 
furin like enzymes. A consensus sequence 
for furin cleavage has been identified on the 
γ subunit by Hughley et al. (10). When the 
furin site was mutated, baseline INa was 
significantly reduced. Probing the γ subunit 
with a C -terminus antibody, the authors 
demonstrated that a 75kD band (76 kD, 
present study) was detected in the total cell 
homogenate (cell surface labeling was not 
performed), but was absent when the furin 
site was mutated. Our data confirm and 
extend their finding by demonstrating that 
the cleavage occurs at the cell surface and 
not intracellularly, suggesting that the 
endogenous amphibian furin (or furin like) 
enzyme is co-expressed and active at the 
plasma membrane. The furin gene family 
encodes  proprotein convertase that is 
expressed in various cellular compartments 
of the exocytic pathway. Proconvertases 
can activate their substrate at the plasma 
membrane. The anthrax toxin receptor is a 
well described example (see review in 
(13)). Hughey  et al. have also identified 
three potential furin cleavage sites on the α 
subunit. When these sites are mutated, 
baseline INa was drastically decreased. A C-
terminus antibody probing the α subunit 
recognized a 65Kd fragment (similar to the 
one described here) which was absent when 
the α subunit was mutated at the three furin 
sites. Our data are at variance with theirs, 
since we could not demonstrate any 
significant precursor-product relationship 
for the α subunit expressed at the cell 
surface vs the intracellular pool.  The 
reason for the discrepancy is not clear. In 
their experiments, a direct correlation 
between the cleaved subunit and activation 
at the membrane was not studied since the 
fragment identified by Western blotting of 
the total cell lysate was not quantified. Our 
approach  allows the quantitation of relative 
changes which occur upon preferential 
assembly and to correlate them with  INa. 
The observed changes are highly significant 
for the γ subunit, but not for the α subunit. 
We cannot rule out the possibility that the 
efficiency of  detection of cleaved 
fragments is lower for α than for γ, making 
quantitation less reliable for the detection of 
α fragments.  
Evidence for a chaperone role of  
the α subunit 
The data presented here are 
consistent with a specific chaperone role of 
the α subunit we have previously proposed 
(8). As shown here, the α subunit alone can 
traffic to the plasma membrane with a low 
activity. This low activity (100 
pAmp/oocyte) was however sufficient to 
originally clone the α subunit (14). The α 
homomeric channel had all the expected 
properties (ion selectivity and amiloride 
sensitivity) of the epithelial sodium 
channel. Because of its low activity, it was 
not possible to measure the single channel 
properties by patch clamp; the gating 
properties of the homomeric channel could 
not be determined. According to the present 
data, α homomeric channel should be in 
“near silent” (open probability Po <0.05) or 
in a closed configuration (Po = 0). It is of 
interest to note that the conformation of α 
homomeric channel might be distinct from 
the heterotetrameric channels. We have 
previously quantified the number of 
channels expressed at the cell surface upon 
assembly into homomeric (α4, β4, γ4), 
heterodimeric (α2β2, α2γ2, β2,γ2) and 
heterotetrameric (α2βγ) channels (2, 6). 
When α subunit was injected alone, no 
significant binding was detected. The 
discrepancy between binding in our 
previous study (6) and biotinylated cell 
surface expressed α subunit protein (in the 
present study) is striking. We speculate that 
α homomeric channels are in a closed 
configuration which masks the extracellular 
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epitope used in our previous studies.  Upon 
assembly with β and γ subunits, a major 
conformational change occurs (potentially 
due to the cleavage of the γ subunit) and 
reveals the epitope, allowing maximal 
antibody binding to all channel subunits.  
Physiological relevance in vivo 
What is the physiological relevance 
of our finding in vivo? The cleavage of the 
γ subunit was first observed in vivo  by 
Masilamani et al. (15). In their study,   long 
term salt deprivation of rats caused a 60 
fold increase in plasma aldosterone and a 
shift in molecular weight of γ ENaC in the 
kidney that was consistent with a 
physiological proteolytic clipping of the 
extracellular loop. This finding was 
confirmed using a 15h salt deprivation 
causing a 2 fold increase in plasma 
aldosterone. Recently Ergonul et al. were 
able to quantitate this effect (16) under 
experimental maneuvers (sodium 
deprivation, potassium loading, aldosterone 
infusion and resalination) which induce a 
large physiological range of plasma 
aldosterone concentrations. The authors 
concluded that changes in the processing 
and maturation of the channels occur 
rapidly enough to be involved in the daily 
regulation of ENaC activity and Na 
reabsorption by the kidney (17). Of interest, 
the processing of the γ subunit measured in 
total protein pool of kidney cortex in vivo is 
consistent with the changes we observed 
here upon channel assembly in vitro. It is 
known that in vivo, aldosterone promotes 
rapid assembly and translocation of channel 
subunits from an intracellular vesicular pool 
to the apical pole and apical membrane of 
the CNT and early collecting duct (18). The 
increased transcription/translation of the α 
subunit would rapidly favor its assembly 
with a pool of preformed β and γ subunits 
and promote their translocation to the apical 
pole or membrane of the aldosterone-
sensitive distal nephron (ASDN), composed 
of the late distal convoluted tubule (DCT), 
the connecting tubule (CNT), and the 
collecting duct (CD). The critical role of the 
α subunit in this process is underscored by 
the lack of channel translocation in CD and 
by the normal translocation in CNT of mice 
genetically engineered to lack the α subunit 
of ENaC in the CD, but leaving ENaC 
expression in CNT intact (19).  Obviously, 
it will be technically challenging to identify 
the molecular species expressed in vivo in 
the apical membrane of ASDN cells. 
Pending such a methodological advance, 
the oocyte expression system remains a 
valid model to study the molecular 
mechanisms of ENaC activation by 
proteolytic processing. 
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FIGURE LEGENDS 
 
Figure 1. Cell surface expression of αrENaC when assembled with βrENaC and/or γrENaC. 
Xenopus oocytes were injected with α, αβ, αγ, or αβγ rENaC cRNAs 24h before experimental 
analysis. The αrENaC subunit was V5 tagged at the C-terminus. A, amiloride-sensitive current was 
measured by voltage clamp in each experimental condition and expressed relative to current in αβγ 
rENaC injected oocytes (959±77nA, n=3 independent experiments). Oocytes injected with αβγ 
rENaC had a significantly higher amiloride-sensitive current than α, αβ, and αγ rENaC injected 
oocytes (*** p<0.001). Cell surface-biotinylated proteins and non-biotinylated proteins were probed 
with V5 antibody to detect the V5 tag inserted in the C terminus of αENaC. B, biotinylated cell 
surface proteins. Full length 95kD αENaC was detected at the cell surface in all conditions. The 
80kD and 65kD αENaC cleavage products were also detected in each experimental condition, 
however their appearance did not correlate with channel activity. C, non-biotinylated protein pool. 
The non-biotinylated protein pool contained the full length 95kD αENaC, as well as the 80kD and 
65kD cleavage products in each experimental condition, however, their appearance did not correlate 
with channel activity. Absence of actin in the biotinylated proteins indicated that no intracellular 
proteins were labeled. Even quantities of actin in the non-biotinylated proteins indicated even protein 
loading. 
 
Figure 2. Densitometry of αrENaC cell surface expression when assembled with βrENaC 
and/or γrENaC. Western blots of biotinylated and non-biotinylated protein in Xenopus oocytes 
injected with V5 tagged αrENaC alone and with βrENaC and/or γrENaC were subjected to 
densitometric analysis (n=3). No significant difference was detected between the experimental 
groups in the 95kD, 80kD, or 65kD bands at the cell surface, nor in the non-biotinylated protein 
pool.  
 
Figure 3. Cell surface expression of βrENaC when assembled with αrENaC and/or γrENaC. 
Xenopus oocytes were injected with β, αβ, βγ, or αβγ rENaC cRNAs 24h before experimental 
analysis. The βrENaC subunit was V5 tagged at the C-terminus. A, amiloride-sensitive current was 
measured by voltage clamp in each experimental condition and expressed relative to current in αβγ 
rENaC injected oocytes (477±166nA, n=3 independent experiments). Oocytes injected with αβγ 
rENaC had a significantly higher amiloride-sensitive current than β, αβ, and βγ rENaC injected 
oocytes (*** p<0.001), and αβ had a significantly higher amiloride-sensitive current than β rENaC 
injected oocytes (*p<0.05). Cell surface-biotinylated proteins and non-biotinylated proteins were 
probed with V5 antibody to detect the V5 tag inserted in the C terminus of βENaC. B, biotinylated 
cell surface proteins. Full length 105kD βENaC was detected at the cell surface in αβγ rENaC 
injected oocytes, corresponding with oocytes exhibiting high channel activity. C, non-biotinylated 
protein pool. The non-biotinylated protein pool contained the full length 105kD βENaC. Absence of 
actin in the biotinylated proteins indicated that no intracellular proteins were labeled. Even quantities 
of actin in the non-biotinylated proteins indicated even protein loading. 
 
Figure 4. Densitometry of βrENaC cell surface expression when assembled with αrENaC 
and/or γrENaC. Western blots of biotinylated and non-biotinylated protein in Xenopus oocytes 
injected with V5 tagged βrENaC alone and with αrENaC and/or γrENaC were subjected to 
densitometric analysis (n=3). Oocytes injected with αβγ rENaC had significantly more 105kD band 
at the cell surface than β, αβ, and βγ rENaC injected oocytes (*** p<0.001). No significant 
difference was detected between the experimental groups in the 105kDa band in the non-biotinylated 
protein pool.  
 
Figure 5. Cell surface expression of γrENaC when assembled with αrENaC and/or βrENaC. 
Xenopus oocytes were injected with γ, αγ, βγ, or αβγ rENaC cRNAs 24h before experimental 
analysis. The γrENaC subunit was V5 tagged at the C-terminus. A, Amiloride-sensitive current was 
measured by voltage clamp in each experimental condition and expressed relative to current in αβγ 
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rENaC injected oocytes (1762±577nA, n=3 independent experiments). Oocytes injected with αβγ 
rENaC had significantly higher amiloride-sensitive current than γ, αγ, and βγ rENaC injected 
oocytes (*** p<0.001), and αγ had significantly higher amiloride-sensitive current than γ rENaC 
injected oocytes (*p<0.05). Cell surface-biotinylated proteins and non-biotinylated proteins were 
probed with V5 antibody to detect the V5 tag inserted in the C terminus of γENaC. B, biotinylated 
cell surface proteins. Full length 87kD γENaC was detected at the cell surface in the αγ rENaC 
injection condition, correlating with 5% channel activity. The 76kD γENaC cleavage product was 
only detected in the αβγ rENaC injected condition, correlating with 100% channel activity. C, non-
biotinylated protein pool. The non-biotinylated protein pool contained predominantly the full length 
87kD γENaC. Absence of actin in the biotinylated proteins indicated that no intracellular proteins 
were labeled. Even quantities of actin in the non-biotinylated proteins indicated even protein loading. 
 
Figure 6. Densitometry of γrENaC cell surface expression when assembled with αrENaC 
and/or βrENaC. Western blots of biotinylated and non-biotinylated protein in Xenopus oocytes 
injected with V5 tagged γrENaC alone and with αrENaC and/or βrENaC were subjected to 
densitometric analysis (n=3). Oocytes injected with αβγ rENaC had significantly more 76kD bands 
at the cell surface than γ (*** p<0.001), αγ, and βγ rENaC injected oocytes (* p<0.05). Also, αγ 
rENaC injected oocytes had significantly more 87kD γ rENaC at the cell surface than oocytes 
injected with γ or αβγ rENaC (* p<0.05). There was significantly less full length 87kD γ rENaC in 
αβγ rENaC injected oocytes than in γ rENaC injected oocytes in the non-biotinylated protein pool (* 
p<0.05). No significant difference was detected between the experimental groups in the 76kD band 
in the non-biotinylated protein pool.  
 
Figure 7. Cleavage of the γ ENaC subunit correlates with channel activation. The 
percent relative abundance of the 76kD (diamond) and 87kD (triangle) bands at the cell 
surface and the 87kD (square) band in the non biotinylated protein  pool were plotted 
together with INa (circle). Increased INa corresponded with increased abundance of the 76kD 
cleavage product at the cell surface and decreased abundance of the full length 87kD at the 
cell surface and in the total protein  pool, suggesting a precursor-product relationship 
between 87kD and 76kD γ ENaC, respectively.  The plot of INa was shifted to the right to 
avoid confusion with the 76kD surface plot, since they are nearly identical. 
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 Results not Contained in the Manuscript: Inhibition of the Furin Cleavage of γ ENaC 
 
To identify the nature of the furin cleavage motif in the γ rENaC subunit, the Xenopus oocyte 
expression system was used. An equivalent mutation to that of the γ mENaC was produced in 
the furin consensus sequence of γ rENaC. Site directed mutagenesis was used to mutate amino 
acid 138 of the RKRR furin cleavage consensus site to alanine giving RKRA, confirmed by 
sequencing reaction. When wild-type and mutated channels were expressed in the Xenopus 
oocytes, mutated channels had INa similar to wild type channels before and after exposure to 
trypsin (Figure 6A). Western blots of these oocytes revealed that γ ENaC cleavage was 
attenuated by the furin consensus site mutation, but that trypsin exposure produced cleavage 
products in both the wild-type and furin mutant channels (Figure 6B). These results suggested 
that cleavage of γ ENaC at the furin consensus site was not responsible for increased channel 
function upon serine protease stimulation, and that other proteases were capable of activating 
this mutated channel.  
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The furin mutant of γ rENaC was studied in parallel with the wild-type γ rENaC to determine 
the kinetics of protease mediated activation of the channel. The time to maximal activation 
(Tmax) of the wild type channel was 2 minutes, similar to previously reported values by 
Chairabi et al. (81). Interestingly, curent tracings revealed that in the furin mutant channels 
Tmax by trypsin was delayed to 4 minutes (Figure 7).  
Figure 6 : A,  mutation of the furin cleavage site doesn’t significantly reduce the INa in 
αβγR138A (gray) injected oocytes compared to controls (black), nor does it prevent channel 
activation by trypsin. * denotes p<0.01 vs. unstimulated channel. (n=3) B, the mutation 
reduced the quantity of γ ENaC cleavage product. Stimulation by trypsin increased the 
quantitiy of cleaved  γ ENaC in wild-type and mutant channels over untreated oocytes. 
Molecular weight standards (M.W.) are indicated in kD. 
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Figure 7 : Representative current tracings and Tmax by trypsin was 
increased from 2 to 4 minutes in wild type αβγ (black) vs. mutant 
channels αβγR138A (grey) respectively. * denotes p<0.01 vs. wild 
type channels (n=3). 
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To further investigate the cleavage of the γ ENaC subunit, α1-PDX, an engineered inhibitor of 
furin, was used to block the protease in the Xenopus oocyte. The inhibitor is an engineered 
serpin that contains the furin consensus motif RXXR (96). When oocytes injected with 
α, β, γ(V5 tagged)  ENaC cRNAs were incubated overnight with 8μM α1-PDX, current was 
decreased by 50% (not statistically significantly), wash-out of α1-PDX did not recover 
currents after 20minutes, and incubation with 100μg/ml aprotinin did not decrease current 
(Figure 8A). These oocytes were also surface labelled with biotin and western blotted. There 
was a reduction in the quantity of 76kD γ ENaC present at the cell surface when oocytes were 
treated with α1-PDX, and this was reversed by washing out the α1-PDX after 20 minutes 
(Figure 8B). There was not a visible difference between the amount of 87kD or 76kD γ ENaC 
present in the non-biotinylated protein pool (Figure 8C). 
 
It was determined in our paper submitted for publication that the γ subunit was not cleaved 
when co-expressed with α, but is present at the cell surface as the uncleaved 87kD full-length 
form. To further investigate the role of the  γ cleavage, Xenopus oocytes were injected with 
αβ or αγ ENaC cRNAs, and exposed to the serine proteases trypsin or elastase. Amiloride-
sensitive currents in oocytes injected with αβ ENaC cRNAs were not significantly increased 
by exposure to trypsin (Figure 9A) or elastase (Figure 9B). Conversely, currents in oocytes 
injected with αγ ENaC cRNAs increased more than four fold after exposure to trypsin (Figure 
9A. p<0.05) and elastase (Figure 9B, p<0.05). This indicated that the stimulatory effect of 
these serine proteases was only effective on ENaC complexes that contained the γ subunit. 
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Figure 8: Oocytes injected with α, β, γ(V5)  ENaC cRNAs were incubated overnight with 
8μM α1-PDX (n=2). A, current was decreased (not significantly) by 50%, wash-out (w.o.) of 
α1-PDX did not recover currents after 20minutes, and incubation with 100μg/ml aprotinin 
(Apr) did not decrease current. B, oocytes were surface labelled with biotin and western 
blotted. There was a reduction in the quantity of 76kD γ ENaC present at the cell surface 
when oocytes were treated with α1-PDX. C, there was not a visible difference between the 
amount of 87kD or 76kD γ ENaC present in the non-biotinylated protein pool. Absence of 
actin in the biotinylated proteins indicated that only cell surface molecules were labelled. 
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Figure 9: Xenopus oocytes injected with αβ and αγ ENaC cRNAs were exposed to trypsin 
(n=4) or elastase (n=4) for 5 minutes. A, trypsin increased amiloride-sensitive current (INa) 
more than ten fold in αγ (* p<0.05) but not αβ injected oocytes. B, elastase increased 
amiloride-sensitive current more than four fold in αγ (* p<0.05) but not αβ injected oocytes. 
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DISCUSSION 
 
Cell surface expression of fully functional ENaC has been shown to be dependant on the co-
expression of α, β, and γ ENaC (62). Expression of ENaC at the cell surface, albeit with 
decreased channel activity has been demonstrated with αβ and αγ channels, but not βγ 
channels (62). The N-terminus SH3 binding region of the α ENaC subunit was shown to be 
responsible for this apical localization in polarized epithelial cells (48). These findings 
indicated that α ENaC was necessary for insertion of the channel complex into the cell 
surface, and for functional activity. 
 
In our experiments, we demonstrate that α ENaC subunit is capable of insertion into the 
plasma membrane of the Xenopus oocyte. This is in disagreement with a previous study by 
Firsov et al., that indicated that α, β, and γ ENaC must be co-expressed for maximal 
surface expression (62). This suggests that homomeric α channels are in a configuration 
which masks the extracellular epitope used in the studies by Firsov et al. This suggested 
that when α, β and γ subunits are assembled a major conformational change occurs 
(potentially due to the cleavage of the γ subunit), which reveals this epitope, allowing 
maximal antibody binding to all channel subunits. The biotinylation labeling technique 
does not depend on a specific epitope but labels all accessable lysine residues in the 
extracellular loop and is therefore less likely masked. Our data is consistent with several 
previous studies which indicate that Xenopus oocytes injected with α, αβ, and αγ subunits 
have amiloride-sensitive currents (59,61), and therefore must have α ENaC at the cell 
surface. The discrepancy between the amiloride-sensitive conductances, despite similar 
levels of α ENaC expression at the cell surface depends on the co-expression of the β and γ 
ENaC subunits and on the cleavage of the γ ENaC subunit, which confers increased 
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channel activity. 
 
The β ENaC subunit was optimally expressed at the cell surface when co-expressed with both 
the α and γ subunits. A small amount of β ENaC subunit was seen at the cell surface when co-
expressed with the α subunit, consistent with the small currents detected in αβ injected 
oocytes. There was less β than α ENaC subunit detected at the cell surface in α and β injected 
oocytes. Perhaps this could be due to inefficient biotinylation, due to masking of lysine 
residues by the abundant glycosylation present on the β ENaC subunit (38). More efficient 
biotinylation of the β ENaC subunit in αβγ ENaC injected oocytes could have been due to a 
conformational change induced by the γ subunit cleavage. This indicated that co-expression of 
αβγ ENaC was essential to achieve maximal surface expression and activity. 
 
Cell surface expression of γ ENaC has been shown to be dependent on co-expression with α 
ENaC (62). Our current measurements and cell surface biotinylation in γ, αγ, βγ, and αβγ 
ENaC injected oocytes were in agreement with these findings. Biotinylation experiments from 
oocytes in these various subunit configurations revealed that αγ ENaC injected oocytes had an 
INa 5% of αβγ ENaC injected oocytes, and cell surface expressed γ ENaC was detected as the 
full length 87kD band. However, αβγ ENaC injected oocytes, which had 20 times the INa of αγ 
ENaC injected oocytes, had cleaved 76kD γ ENaC at the cell surface. The relationship 
between surface expression of γ ENaC and the amount of INa is in agreement with previous 
findings (61). The INa and cleavage was highly correlated between αγ and αβγ injected 
oocytes suggesting that cleavage was responsible for channel activation. The presence of 
87kD γ ENaC at the cell surface in αγ ENaC injected oocytes indicated that cleavage of the γ 
subunit was occurring at the cell surface upon co-expression with α and β, and the presence 
of predominantly 76kD γ ENaC at the cell surface in αβγ ENaC injected oocytes indicated 
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that this cleavage was extremely efficient. Activation of αγ but not αβ ENaC complexes by 
trypsin and elastase further confirmed γ ENaC as the proteolytic target of serine proteases. 
 
Our observed cleavage of rat γ ENaC is in agreement with previously reported experiments 
with  mouse γ ENaC in transfected MDCK cells (40). The cleavage site in mouse γ ENaC was 
reported to be at AA 143, which corresponds well to our cleavage site location in rat γ ENaC. 
Experiments with the γ ENaC furin cleavage mutant R143A revealed that endogenous 
cleavage products were indeed cleaved at this site. However, this mutation was not sufficient 
to abolish stimulation or cleavage of the channel by the serine protease trypsin, but did cause 
a reduction in the time required to achieve maximal activation by trypsin. These findings 
suggest that endogenous cleavage of the γ ENaC subunit at AA143 changes subunit 
conformation and increases Tmax by externally applied trypsin. Inhibition of furin cleavage of 
the γ ENaC subunit with the engineered protease inhibitor α1-PDX further confirmed that 
furin was associated with cleavage. Nonetheless, these results must be interpreted with 
caution since furin is involved with multiple essential cell functions (74). Inhibition of furin 
could be affecting many processes, including the processing and activation of other serine 
proteases capable of activating ENaC. The furin consensus motif is also a prostasin consensus 
motif (92), and contains R and K AA’s known to be the target of trypsin. Indeed, the 
activation of furin mutants by trypsin revealed that the proteolysis of γ ENaC is possible at 
more than one location (R143) in the extracellular loop.  
 
Recently it has been shown that furin liberates an inhibitory fragment of the α and γ ENaC 
subunits (41,42). These results should also be interpreted with caution since it is known that 
these inhibitory fragments are short polybasic AA sequences (41,42). Short polybasic AA 
sequences have recently been shown to be potent inhibitors of proprotein convertases 
- 75 - 
including furin as well as trypsin (97). These short polybasic fragments would therefore 
inhibit furin in the target cell and would have the same effect of α1-PDX by inhibiting several 
essential cell functions (74), and may not be specific to ENaC. 
 
Taken together our data indicate that ENaC processing involves cleavage of the γ but not the 
α ENaC subunit. Cleavage of the γ ENaC subunit is in agreement with in-vivo studies of 
rodents subjected to low salt diets or aldosterone infusion. However, some studies also show 
cleavage of the α ENaC subunit. When animals are put on a low salt diet, or are infused with 
aldosterone, ENaC subunits are translocated from an internal pool to the plasma membrane in 
the distal nephron (36,43). Apical translocation in response to low salt diet and aldosterone 
infusion correlates with increased ENaC activity and cleavage of the α and γ ENaC subunits 
(44). Conversely, cleavage of only the γ ENaC subunit is more frequently observed, and 
displays a precursor-product relationship between the 87kD and 76kD bands whereas the α 
ENaC cleavage does not (43,44,98,99). Lack of precursor-product relationship in α ENaC 
cleavage at the cell surface suggests that the cleavage is the result of subunit degradation. The 
precursor-product relationship of γ ENaC demonstrated at the cell surface in our experiments 
and in these in-vivo experiments suggests that increased channel activity is related to a 
conversion of a low activity 87kD form to a high activity 76kD form of γ ENaC.  
 
It has been demonstrated that ENaC can be activated by furin, trypsin, chymotrypsin, and 
elastase. What is striking is that the target AA specificity between these serine proteases is 
extremely different. Trypsin is specific for positively charged AA’s such as lysine and 
arginine (70). Chymotrypsin has a specificity for large aromatic residues phenylalanine, 
tyrosine, and tryptophan (71). Elastase has a substrate specificity for small hydrophobic 
amino acids alanine, valine, and serine (72).  Therefore, one should be cautious in suggesting 
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a specific cleavage site in γ ENaC, which is essential for activation when 40% of the AA 
residues in the extracellular loop are potential cleavage activation sites. Specificity of serine 
proteases for γ ENaC is likely dictated by the conformation of the extracellular loop, which 
sterically hinders access of serine proteases to their target sequences. This steric hinderance 
could be mediated by glycosylation of the extracellular loop outlined in Figure 3. The 
extracellular loop distal from H1 contains a region that is consistantly a target for furin, 
trypsin, and prostasin. This suggests that this region has the least steric hinderance to 
proteases. Given the diverse AA specificity of proteases demonstrated to cleave in this region, 
it is likely that several cleavage sites are capable of increasing channel activity. 
 
The γ ENaC cleavage product observed in-vivo is consistently less than or equal to 70kD 
(43,44,99), suggesting that the furin cleavage site may be less relevant, and γ ENaC cleavage 
may be mediated by other serine proteases. Mutation of the furin consensus site (R143) in γ 
rENaC did not prevent channel activation by trypsin, further confirming this hypothesis.  
Delayed channel activation by trypsin in the furin mutant indicated that a cleavage cascade 
may be involved in channel activation. This would involve cleavage at the furin site followed 
by subsequent cleavage activation by trypsin or other proteases at another nearby site. Indeed, 
a recent study indicated that there is a more distal cleavage site in γ ENaC that is cleaved by 
prostasin giving a 70kD band by Western blot (42), which is the size of the cleavage product 
seen in-vivo. These in-vitro and in-vivo experiments consistently report cleavage of the γ 
ENaC subunit correlating with increased ENaC activity. 
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Engineered Human Neutrophil Elastase Inhibitor EPI-hNE4 Prevents 
Elastase Stimulation of Amiloride-sensitive Current in hENaC 
Injected Xenopus laevis Oocytes 
Aim 2  
Determine if ENaC cleavage can be involved in disease states such as cystic fibrosis (CF), 
where elevated protease concentrations could lead to increased ENaC activity. Using the 
oocyte expression system as previously outlined, we wished to determine if ENaC activation 
by serine proteases could occur in CF, potentially worsening the symptoms of the disease. 
 
INTRODUCTION 
CF is a disease that is characterized by mutation of the cystic fibrosis transmembrane 
regulator (CFTR) gene (100). CFTR is responsible for Cl- driven fluid secretion in the lung, 
and inhibiting antagonistic fluid absorption through ENaC (101-104). CF patients thus 
experience inappropriately increased fluid absorption in the lung due to the lack of fluid 
secretion by CFTR and increased fluid absorption by ENaC. This imbalance of fluid 
absorption leads to decreased pericilliary liquid (PCL) levels, which leads to lung 
abnormalities in CF patients. Mall et al., have recently established that increased lung ENaC 
expression and activity in transgenic mice causes “cystic fibrosis-like lung disease” by 
decreasing PCL levels (23), suggesting that over-activity of ENaC contributes to the CF 
phenotype. 
 
Numerous studies have shown that several serine proteases are capable of increasing ENaC 
mediated INa in multiple cell types (63,79-84,86-89), including the in-vitro and in-vivo rodent 
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lung (90). Since ENaC over-activity is capable of inducing a CF-like phenotype, then 
proteolytic activation of ENaC should be detrimental to patients with CF.  
 
The serine protease, neutrophil elastase (NE) has been shown to reach concentrations greater 
than 200μg/ml in the lung of patients with CF (105,106), whereas healthy subjects have 
undetectable levels of NE (105). The NE in the lungs of patients with CF is known to cause 
cellular damage (107), production of the pro-inflammatory cytokine Il-8 (105), and cause 
increased neutrophil influx (106). If NE is also capable of activating ENaC and thereby 
exacerbating the CF phenotype, then actions taken to reduce this activation could be very 
beneficial to CF patients. Recently, Caldwell et al. have shown that human NE is capable of 
stimulating INa in a human bronchiole cell line, and that an elastase inhibitor can prevent NE 
mediated stimulation (89).  
 
NE inhibitor therapy is currently being pursued by the pharmaceutical industry to treat CF and 
congestive obstructive pulmonary disease (COPD), by preventing NE induced lesions in the 
pulmonary epithelium. In this study we have examined the effectiveness of one of these 
compounds, EPI-hNE4 an engineered NE inhibitor (Debiopharm SA, Lausanne, Switzerland) 
that was designed to be resistant to oxidative and proteolytic inactivation, for its ability to 
inhibit NE mediated stimulation of ENaC.  
 
HYPOTHESIS 
 
We wished to determine if NE can activate ENaC, and that the NE inhibitor EPI-hNE4 can 
prevent this activation. Specifically we hypothesized : 
1. NE activates ENaC by cleaving cell surface expressed γ subunit. 
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2. Channel activation and cleavage of the γ ENaC subunit can be blocked by the NE 
inhibitor EPI-hNE4. 
 
RESULTS 
The following 17 pages contain an article published November 7, 2006 in the Journal of 
Biological Chemistry. Your candidate has performed almost all aspects of this experiment 
including cRNA synthesis, cRNA microinjection into Xenopus oocytes, measurement of INa 
by TEV, cell surface biotinylation, SDS-PAGE, Western blotting, and blot analysis by 
densitometry. Nicole Fowler-Jaeger performed extraction of oocytes from Xenopus laevis. 
The plasmids containing α, β, and γ ENaC subunits tagged with V5 at the carboxy terminus 
was a gift from M. Jackson Stutts (University of North Carolina, Chapel Hill, U.S.A.). The 
EPI-hNE4 was a gift on behalf of Debiopharm SA (Lausanne, Switzerland) by Grégoire 
Vuagniuax. Your author and Bernard Rossier wrote the manuscript. Your author, Bernard 
Rossier, Dmitri Firsov, M. Jackson Stutts, Jean-Daniel Horisberger, Birgitte Monster-
Christensen, and Nicole Skarda edited the manuscript. 
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The amiloride-sensitive epithelial 
sodium channel (ENaC) constitutes a 
limiting step in sodium reabsorption across 
distal airway epithelium and controlling 
mucociliary clearance. ENaC is activated by 
serine proteases secreted in the extracellular 
milieu. In cystic fibrosis (CF) lungs, high 
concentrations of secreted neutrophil 
elastase (hNE) are observed.  hNE could 
activate  ENaC and contribute to further 
decreased mucociliary clearance. The aims 
of this study were: i)  to test the ability of an 
engineered human neutrophil elastase 
inhibitor (EPI-hNE4) to specifically inhibit 
the hNE activation of  ENaC-mediated 
amiloride-sensitive currents (INa) ; ii) to 
examine the effect of hNE on cell surface 
expression of ENaC and its cleavage pattern 
(exogenous proteolysis).  Oocytes were 
exposed to hNE (100μg/ml), and/or trypsin 
(10μg/ml) for 2 minutes in the presence or 
absence of EPI-hNE4 (0.7μM). hNE 
activated INa more than 3.5 fold (P<0.001), 
relative to non-treated hENaC injected 
oocytes. EPI-hNE4 fully inhibited hNE 
activated INa, but had no effect on trypsin- 
or prostasin- activated INa. The co-activation 
of INa by hNE and trypsin was not additive. 
Biotinylation experiments revealed that cell 
surface  γ ENaC  (but not α, nor β ENaC) 
exposed to hNE for 2 minutes was cleaved 
and correlated with increased INa. The hNE-
induced proteolysis of  γ ENaC which 
produces a 67kD fragment is distinct from 
the endogenous proteolysis which produces 
a 76kD fragment, suggesting a causal 
relationship between  ENaC cleavage and 
ENaC activation, taking place at the plasma 
membrane.  
INTRODUCTION 
 
The highly sodium selective epithelial 
sodium channel (ENaC) is composed of three 
homologous subunits (α,β,γ) and is expressed 
in several ion transporting epithelia, including 
the kidney, colon, and lung(1).  The 
physiological importance of ENaC in the lung 
was recognized when α ENaC knockout mice 
were shown to die prematurely, due to 
defective lung liquid clearance (2), indicating 
ENaC as a major driving force for  fluid 
reabsorption from the alveolar space at the 
time of birth. Active transepithelial sodium 
transport by surface airway epithelia provides 
a major driving force for the control of airway 
surface liquid (ASL) and periciliar liquid 
(PCL), highly critical for mucociliary 
clearance(3);(4). ENaC, located at the apical 
membrane of the surface airways epithelium 
(SAE), constitutes a limiting step for sodium 
absorption by SAE, as shown by human 
genetic diseases(5). Thus, loss of function of 
ENaC, as observed in 
pseudohypoaldosteronism (PHA-1), leads to a 
2-3 fold increase in mucociliary clearance (6). 
By contrast, increased ENaC activity, 
secondary to a loss of function of CFTR, is 
observed in cystic fibrosis (CF) patients. 
Cystic fibrosis (CF) is a disease that is 
characterized by mutation of the cystic fibrosis 
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transmembrane regulator (CFTR) gene(7). 
CFTR is responsible for Cl- driven fluid 
secretion in upper and lower airways, and is 
inhibiting antagonistic fluid absorption through 
ENaC (8);(9). CF patients, thus, experience a 
severe decrease in mucociliary clearance (10). 
Mall et al.(11) have recently established that 
increased  ENaC expression and activity in 
airways of transgenic mice may cause per se a 
’cystic fibrosis-like lung disease’(11), 
characterized by a decreased mucociliary 
clearance and  tissue inflammation even in 
absence of microbial infection. Together, these 
findings suggest that over-activity of ENaC 
contributes significantly to the CF phenotype. 
Thus, ENaC becomes a valid drug target for 
treating CF patients. 
Numerous studies have shown that 
several serine proteases are capable of 
increasing ENaC mediated INa in multiple cell 
types(12), including the in-vitro and in-vivo 
rodent lung (13-15). The activation of ENaC 
by serine proteases may be a direct 
consequence of proteolytic cleavage(16) by a 
dramatic change in its open probability 
(Po)(17). Since over-activity of ENaC is 
capable of inducing a CF-like phenotype, 
proteolytic activation of ENaC could be 
detrimental to CF patients.  
The serine protease, neutrophil elastase 
(hNE) has been shown to reach concentrations 
greater than 200μg/ml in the lung of patients 
with CF (18) and to overcome antiprotease 
activity(19), whereas healthy subjects have 
undetectable levels of hNE. The hNE in the 
lungs of patients with CF is known to cause 
cellular damage, production of the pro-
inflammatory cytokine Il-8 and increased 
neutrophil influx (20);(21);(22). If hNE is also 
capable of activating ENaC, it would thereby 
exacerbate the CF phenotype, and actions 
taken to reduce this activation could be  
beneficial to CF patients. Recently, Caldwell et 
al. have shown that hNE is capable of 
stimulating INa in a human bronchiole cell line, 
and that an hNE inhibitor can prevent hNE 
mediated stimulation (23).  
HNE inhibitor therapy is currently 
being developed to treat CF and COPD by 
preventing hNE induced lesions in the 
pulmonary epithelium. In this study, we have 
examined the effectiveness of one of these 
compounds, EPI-hNE4, an engineered hNE 
inhibitor that was designed to be a specific, 
high affinity drug, resistant to oxidative and 
proteolytic inactivation.  
We have hypothesized that hNE can cleave 
cell surface expressed ENaC, which results in 
channel activation, and that EPI-hNE4 can 
prevent this cleavage/activation. In order to 
identify if ENaC was being directly cleaved by 
hNE, oocytes were analyzed for increased 
ENaC mediated INa, and for proteolytic 
cleavage of cell surface proteins.  Here, we 
present data indicating that hNE is capable of 
activating ENaC, possibly by cleaving cell 
surface expressed γENaC, and that this effect 
can be blocked by the hNE specific inhibitor 
EPI-hNE4. The hNE induced cleavage 
(exogenous proteolysis) is distinct from the 
cleavage pattern observed upon preferential 
assembly of α, β and γ ENaC subunits by 
oocyte proteases (endogenous proteolysis), 
suggesting a causal relationship between 
cleavage and ENaC activation. 
 
Experimental procedures 
 
cRNAs. Complementary RNAs of human or rat 
αβγ ENaC subunits, and human prostasin were 
synthesized in vitro, using SP6 and T7 
polymerase. C-terminus V5 epitope 
tagged α, β  and γ ENaC subunits were kindly 
provided by M. J. Stutts.  
Antibodies. Monoclonal anti-V5 antibody 
was obtained from InVitrogen and used per 
manufacturer’s instruction. 
The actin antibody was from Sigma.  
Expression of ENaC and human prostasin 
cRNA in Xenopus oocytes. The cRNAs 
were injected into Xenopus oocytes (3.3 ng of 
each subunit and 3.3 ng of human CAP-
1(prostasin) = 13.2 ng of total cRNA/oocyte) 
and injected oocytes were kept in modified 
Barth solution (MBS) containing 88 mM NaCl, 
1 mM KCl, 2.4 mM NaHCO3, 0.8 mM 
MgSO4, 0.3 mM Ca(NO3)2, 0.4 mM CaCl2, 10 
mM Hepes-NaOH (pH 7.2). 
Electrophysiological measurements and cell 
surface biotinylation were performed 24 hours 
after injection. Amiloride-sensitive Na+ current 
(INa) was recorded, using the two-electrode 
voltage clamp and was defined as the 
difference between Na+ current obtained in the 
presence (5 μM) and in the absence of 
amiloride. 
Incubation of Xenopus oocytes with proteases 
and inhibitors. ENaC injected oocytes were 
incubated for 2 minutes at room temperature in 
MBS solution containing proteases and/or 
inhibitors. hNE from human neutrophils (Serva 
Electrophoresis) was used at a concentration of 
10 or 100μg/ml, trypsin (Sigma) was used at a 
concentration of 10μg/ml, engineered human 
hNE inhibitor (Debiopharm S.A.) was used at 
a concentration of 44μg/ml, and aprotinin was 
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used overnight at a concentration of 100μg/ml. 
At the end of the incubation, hNE inhibitors 
were added to all samples before biotinylation. 
Biotinylation of ENaC subunits on the cell 
surface.   Biotinylation was performed in 
40 well plates, using 50 oocytes per 
experimental condition, as described(24). All 
biotinylation steps were performed at 4˚C. 
After incubation in MBS solution for 30 min at 
4˚C, the oocytes were washed three times with 
MBS. After the last wash, the MBS solution 
was removed and replaced by a biotinylation 
buffer containing 10 mM triethanolamine, 150 
mM NaCl, 2 mM CaCl2, 1 mg/ml EZ-link 
sulfo-NHS-SS-Biotin (Pierce), pH 9,5. The 
incubation lasted 15 min with gentle agitation. 
The biotinylation reaction was stopped by 
washing the oocytes two times with Quench 
buffer containing 192 mM glycine, 25 mM 
Tris-Cl (pH 7,5), added to MBS solution. After 
the second wash, oocytes were incubated for 5 
min in the Quench buffer with gentle agitation. 
Oocytes were then washed two times with 
MBS solution, then lysed by repeated pipetting 
with Pasteur pipettes in Lysis buffer containing  
1% Triton X-100, 500 mM NaCl, 5 mM 
EDTA, 50 mM Tris-Cl, 5μg/ml each of 
leupeptin, antipain, and pepstatin, 10μg/ml 
aprotinin, and 4.4μg/ml EPI-hNE4 (20 
μl/oocyte). The lysates were vortexed for 30 
sec and centrifuged for 10 min at ∼10,000g. 
Supernatants were transferred to the new 1.5 
ml Eppendorf tubes containing 50 μl 
immunopure immobilized streptavidin beads 
(Pierce) washed with Lysis buffer. After 
overnight incubation at 4˚C with agitation, the 
tubes were centrifuged for 1 min at 5’000 rpm. 
Supernatant was removed and beads were 
washed three times with Lysis buffer. 35 μl of 
2x SDS-PAGE sample buffer was added to the 
beads. All samples were heated for 5 min at 
95°C before loading on the 8-15% SDS-
PAGE.  
RESULTS 
 
The endogenous processing of ENaC 
in the Xenopus oocyte expression system is 
significant and specific for each subunit.  
Hughey, et al. have implicated furin in ENaC 
proteolytic processing (16).  It is not known if 
other enzymes are involved and it is not clear 
whether this processing is related to the 
activation of ENaC at the cell surface.   The 
study of exogenous secreted serine proteases 
(trypsin, hNE) could help in understanding 
whether ENaC cleavage is required for 
activation or not. We coupled the use of hNE 
with a highly specific inhibitor to study the 
relationship between cleavage of ENaC at the 
cell surface and the sodium transport response.   
Engineered elastase inhibitor EPI-hNE4 
specifically inhibits human hNE and not 
trypsin stimulation of  hENaC. To determine 
if EPI-hNE4 was capable of inhibiting hNE 
mediated stimulation of hENaC, we used the 
Xenopus oocyte expression system to over-
express hENaC proteins by injecting α, β, and 
γ hENaC subunit cRNAs. Xenopus oocytes 
injected with hENaC were exposed to 
100μg/ml hNE for 2 minutes and INa was 
measured, using the two-electrode voltage 
clamp system. Exposure of the Xenopus 
oocytes to hNE in MBS solution resulted in a 
more than 3.5 fold increase in INa over 
untreated oocytes (Figure 1, lane 2 vs lane 1). 
This stimulation of hENaC (lane 2) was 
significantly inhibited in oocytes exposed to 
hNE in the presence of the hNE inhibitor EPI-
hNE4 (lane 3), suggesting that the catalytic 
activity of hNE is involved in the activation of 
ENaC.  Trypsin stimulated INa in hENaC 
injected oocytes more than 5.5 fold over non-
treated oocytes (lane 4), but EPI-hNE4 did not 
inhibit trypsin-induced activation of hENaC 
(lane 5), demonstrating the specificity of the 
inhibitor for hNE. Thus, both hNE and trypsin 
activate ENaC. In order to determine if the 
activation pathways for these proteases were 
similar, hENaC injected oocytes were exposed 
to trypsin alone (lane 4) or to hNE and trypsin, 
together (lane 6). Simultaneous exposure to 
hNE and trypsin resulted in a 5 fold increase in 
INa (lane 6), but no additive effect was 
observed (compare lanes 6 vs. 4 and 6 vs. 2). 
This non-additive stimulation of INa in hENaC 
injected oocytes by hNE and trypsin suggested 
that the two proteases act on a common 
pathway for ENaC activation, which involves 
proteolytic cleavage of the channel itself, or 
one of its regulatory proteins. The possibility 
that the expression system was translationally 
saturated was ruled out by  injecting ten times 
more ENaC cRNAs, leading to a more than 10 
fold increase in INa (lane 7). 
EPI-hNE4 does not inhibit amiloride-sensitive 
Na+ transport induced by co-injected 
prostasin. Channel Activating Proteases 
(CAPs) are membrane bound serine 
proteases(12) known to be expressed, and to 
regulate ENaC in the lung(13);(14). To 
determine if EPI-hNE4 was capable of 
inhibiting exogenously expressed membrane 
proteases, hENaC injected oocytes were co-
injected with  human CAP-1 (prostasin) 
(Figure 2), a serine protease known to be 
expressed in airway epithelia, and known to 
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increase amiloride-sensitive INa.  Oocytes co-
injected with hCAP-1 and  hENaC 
significantly increased INa (3 fold) (lane 2) 
over hENaC injected oocytes (lane 1).  
Increasing concentrations of EPI-hNE4 added 
at the time of cRNA injection (lane 3 to 5) 
were unable to significantly decrease the CAP-
1 induced increase in INa. This further indicated 
that EPI-hNE4 is specific for hNE and does 
not affect human CAP-1 (prostasin) activity. 
As shown previously, the protease inhibitor 
aprotinin (added at the time of cRNA 
injection) was able to significantly decrease 
the prostasin mediated increase in INa (lane 6), 
indicating that inhibition of CAP-1-mediated 
stimulation was effective. EPI-hNE4 had no 
significant effect on amiloride sensitive INa, 
when applied in the absence of hNE (lane 7). 
Aprotinin had no significant effect on basal 
currents (lane 8). 
NE cleaves γ rENaC, but not  α  and β rENaC, 
and is specifically inhibited by EPI-hNE4.   
Recently, Hughey et al. have shown that ENaC 
is  proteolytically processed  (16,25). It was 
demonstrated  that cell surface expressed 
ENaC proteins are cleaved, and that cleavage 
correlated with channel activity. This 
suggested that intracellular proteolytic 
cleavage was involved in channel maturation 
(25). The mechanism of extracellular protease 
stimulation of ENaC activity has not been 
identified. We wished to determine if 
extracellular stimulation of ENaC by hNE was 
correlated with direct cleavage of the channel 
at the cell surface.  
Three injection conditions were used to 
examine cleavage of V5 epitope tagged α, β, 
and γrENaC subunits in Xenopus oocytes. 
Oocytes were injected with V5 tagged αrENaC 
and wild-type β, γrENaC, V5 tagged βrENaC 
and wild-type α, γrENaC, and V5 tagged 
γrENaC and wild-type α, βrENaC. These 
oocytes were exposed to 10μg/ml hNE which 
increased amiloride-sensitive Na+ current (INa) 
more than 5 fold in each condition (P<0.05, 
N=5) within 2 minutes (Figures 3A, 4A, 5A, 
lane 2 vs. lane 1). This stimulation of rENaC 
by hNE was significantly inhibited (P<0.05) 
when the hNE inhibitor EPI-hNE4 was present 
in the MBS solution (Figures 3A, 4A, 5A, lane 
3 vs. lane 2). To determine if hNE activation 
was mediated by direct cleavage of the cell 
surface expressed protein, cell surface 
biotinylation was performed. The same pool of 
Xenopus oocytes injected with rENaC and 
exposed briefly (2 min) to hNE alone, or hNE 
and EPI-hNE4 together, were biotinylated to 
separate membrane and intracellular proteins. 
Biotinylated and non-biotinylated V5 tagged 
αrENaC coinjected with β, and γrENaC was 
separated on a 8-15% gradient PAGE, and 
transferred to a nitrocellulose membrane for 
Western blotting, and probed with V5 antibody 
(Figure 3, panel B). Control oocytes as well as 
those exposed to hNE, and hNE4 in the 
presence of EPI-hNE4 (lanes 1-3 respectively) 
had a major band at 95 kD, as well as 80 kD 
and 65 kD fragments, corresponding to the full 
length αENaC molecule, and two endogenous 
cleavage products. The non-biotinylated 
protein pool (Figure 3, panel C) similarly 
expressed the 95 kD full length αENaC 
molecule, but not the 80 kD, and 65kD 
fragments in all ENaC injected conditions 
(lanes 1 to 3). These products were ENaC 
specific and not observed in water injected 
oocytes (lane 4).  Absence of actin in the 
biotinylated cell surface proteins and its 
presence in the non-biotinylated protein pool 
confirmed that the biotinylation reaction did 
not label intracellular proteins. This result 
indicated that α ENaC was not cleaved by 
hNE, but was cleaved by endogenous 
proteases.  
V5 tagged βrENaC co-injected with α, 
and γrENaC was also Western blotted, and 
probed with V5 antibody. β ENaC was 
expressed as a single band of 105 kD at the 
cell surface (Figure 4, panel B, lane 1 to 3), as 
well as in the non-biotinylated protein pool 
(Figure 4, panel C lanes 1 to 3), in all ENaC 
injected conditions. These products were 
ENaC specific and not observed in water 
injected oocytes (lane 4).  This result indicated 
that β ENaC was not cleaved by hNE, nor by 
intracellular proteases.  
V5 tagged γrENaC co-injected with α, 
and βrENaC was also Western blotted, and 
probed with V5 antibody. Control oocytes as 
well as those exposed to hNE, and hNE4 in the 
presence of EPI-hNE4 (Figure 5, panel B, 
lanes 1-3 respectively) exhibited a band of 87 
kD, as well as a 76 kD fragment, 
corresponding to the full length γENaC 
molecule, and the endogenous cleavage 
product respectively. In addition, the hNE 
treated oocytes exhibited an additional 
fragment of 67kDa (Figure 5, panel B, lane 2 
*), which was not present when oocytes were 
exposed to hNE in the presence of EPI-hNE4 
(Figure 5, panel B, lane 3). The non-
biotinylated protein pool (Figure 5, panel C) 
similarly expressed the 87 kD full length 
γENaC molecule, as well as the 76 kD 
fragment, but not the 67kD fragment in all 
ENaC injected conditions (lanes 1 to 3). These 
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products were ENaC specific and not observed 
in water injected oocytes (lane 4). This result 
indicated that γ ENaC was cleaved by 
endogenous proteases, and further cleaved by 
hNE at the cell surface.  
Western blot densitometry was performed 
(Bio-Rad, Molecular Imager FX) to quantify 
the appearance of the hNE induced 67kD 
γrENaC fragment at the cell surface (Figure 
6A), and in the non-biotinylated total pool 
(Figure 6B). Band densities of 5 independent 
Western blots were normalized to full length 
87 kD γ ENaC in untreated oocytes (Figure 
6A, 6B, lane 1). Biotinylated cell surface 87 
kD γ ENaC band density was not significantly 
altered by exposure to hNE alone, nor when 
co-incubated with its inhibitor EPI-hNE4 
(Figure 6A, lanes 2 and 3). Cell surface 76 kD 
γ ENaC was similarily not affected (lanes 4-6). 
The hNE induced 67 kD fragment was 
significantly increased by hNE treatment (lane 
8, *P<0.05) over untreated controls (lane 7). 
The appearance of the hNE induced 67 kD 
fragment was prevented by inhibiting hNE 
with EPI-hNE4 (lane 8 vs. lane 7, #P<0.05).  
The non-biotinylated total pool 87 kD and 76 
kD γrENaC band densities were not 
significantly affected by treatment with hNE, 
nor hNE with EPI-hNE4 (Figure 6B, lanes 1-
6). The 67 kD γrENaC band was not detected 
in the non-biotinylated total pool protein 
(Figure 6B, lanes 7-9). These results indicated 
that the hNE induced 67 kD γrENaC cleavage 
product was significantly increased relative to 
non-hNE treated controls, and that inhibition 
of hNE by EPI-hNE4 prevented the formation 
of this cleavage product. The presence of the 
67 kD γrENaC cleavage product at the cell 
surface and not in the non-biotinylated total 
protein pool indicated that hNE was acting 
uniquely on cell surface expressed γrENaC and 
not on the intracellular γrENaC proteins. 
 
 
DISCUSSION 
 
Elastase induced ENaC activation and 
cleavage at the cell surface: evidence for 
specific exogenous proteolysis.. Recent 
evidence clearly indicates that ENaC activation 
can be directly induced by exposing membrane  
patches  to external trypsin or hNE (17). The 
effect is rapid, characterized by a large change 
in ENaC open probability (Po). Obviously, this 
approach does not allow the correlation of 
ENaC activity with  proteolysis.  
In the present study, we took 
advantage of the very rapid ENaC activation 
(within 2 minutes) by external application of 
hNE,  which can then be correlated with the 
pattern of proteolysis at the cell surface in the 
same oocytes. A short time course (2minutes) 
minimizes endo- or exocytosis so that only the 
pool of ENaC molecules pre-existing at the 
plasma membrane are studied.  We used a 
highly specific hNE inhibitor to definitively 
assign induced functional and biochemical 
events to hNE catalytic activity.  Using this 
protocol we demonstrate that the γ ENaC 
subunit undergoes cell surface specific 
cleavage (within two minutes), since they are 
not observed in the intracellular pool. The 
induced fragment is 67 kD,(* Figure 5). Cell 
surface cleavage was efficiently prevented by 
the hNE inhibitor EPI-hNE4.  It is therefore 
tempting to speculate that these various cell 
surface specific cleaved forms of γ ENaC are 
functionally responsive of the activation of 
"near silent" channels observed in membrane 
patches. In other words, the change in Po may 
not only correlate with, but be caused by 
proteolysis. How could cleaving a channel 
increase its Po? This is not so unlikely if one 
considers the number of biological processes, 
which are activated by proteolytic cleavage:  
prohormones (i.e. insulin), which are activated 
by cleavage. Serine proteases, secreted as 
inactive pro-enzymes and activated into 
zymogens by intramolecular cleavage, are well 
established examples. A similar scheme could 
also apply to an ionic channel, such as ENaC. 
ENaC is characterized by its unusual gating 
kinetics, with postulated transitions from 
different modes,  i.e. from low Po (i.e. "near 
silent", Po< 0.05) to high Po gating modes (Po 
>0.8)(1).  These different gating modes could 
correspond to the  cleavage of γ ENaC. 
Importantly, the β subunit is insensitive to both 
endogenous and exogenous proteolysis (Figure 
4). We have no explanation for this resistance. 
One can, however, speculate that the N-
glycosylation  of the β subunit might play a 
role since the β subunit has no less than 12 N-
glycosylation sites. This could protect the  
proteolytic cleavage sites from enzyme access 
to their substrate. In addition, it is worth noting 
that the primary sequence of the β subunit does 
not have any consensus sequences for cleavage 
by furin. So, differences in primary sequence 
and protein folding/maturation may explain the 
striking difference between the β, and γ 
subunits. 
Interestingly the α ENaC subunit undergoes 
endogenous cleavage producing an 80 kD 
fragment and a 65 kD fragment at the cell 
surface (Figure 3, panel A). These cleavage 
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products are not seen in the non-biotinylated 
intracellular pool (Figure 3, panel B) as an 
abundant form of the channel. However, 
overexposure of the Western blot reveals that 
these fragments are present intracellularly in 
low quantities relative to the full length 95 
kD α ENaC  (data not shown). Taken together 
these data indicate that α ENaC is 
endogenously processed late in its maturation, 
consistant with a furin cleavage profile, which 
occurs in the late Golgi or at the cell surface.  
Our Western blots of α ENaC indicate that  
hNE is unable to further cleave this subunit. 
However in a small percentage (6%) of our 
western blots, cleavage of the α ENaC subunit 
is observed upon exposure to hNE. This is 
however inconsistent with the activation of INa 
by hNE which is observed in all experiments 
irrespective of the hNE specific cleavage of α 
ENaC. This is in contrast to the hNE induced 
67 kD γ ENaC cleavage product which is 
observed to correlate 100% with induction of 
INa.  
Physiological and patho-physiological 
implications of SP and SPI. Our findings 
are relevant to the development of novel drug 
therapies for patients suffering from CF. In this 
disease, mucociliary clearance is severely 
decreased.  Mucociliary clearance is critically 
dependent on the control of the periciliar liquid 
(PCL). Combined defects of accelerated Na+ 
transport and the failure to secrete Cl-  depletes 
the PCL compartment, abrogating both cilia-
dependent and cough clearance. Subsequent to 
PCL depletion, mucus adheres to airway 
surfaces and persistent mucin secretion 
generates the formation of "thickened" mucus 
plaques and plugs, which become the nest for 
bacterial infection(10). This pathogenic 
scheme has been validated by the generation of 
a mouse model overexpressing the βENaC 
subunit in distal airways, that led to a PCL 
depletion and CF lung phenotype mimicking 
the human disease (11).  In this setting, ENaC 
becomes a valid target for the treatment of CF 
lung disease. The inhibition of ENaC by 
amiloride has already been shown to be 
effective in increasing mucociliary clearance 
(26). Similar beneficial effects can be observed 
by inhalation of hypertonic saline, producing a 
sustained acceleration of mucus clearance and 
improved lung function(27). Inhibition of hNE 
by the specific inhibitor would have dual and 
synergistic effects on CF airways: blocking 
ENaC activity, thereby repleting PCL and 
improving mucociliary clearance and blocking 
the effect of hNE on tissue inflammation and 
destruction. This inhibitor would have the 
advantage of not interfering with the 
physiological control of ENaC by endogenous 
lung serine proteases, such as prostasin or 
other membrane bound serine proteases, 
expressed in airway epithelia (15).  
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FIGURE LEGENDS 
 
 
 
Figure 1. Engineered elastase inhibitor EPI-hNE4 specifically inhibits hNE, and not 
trypsin stimulation of  hENaC. Oocytes were injected with αβγhENaC cRNAs 24 hours 
before experimental analyses. Oocytes were exposed to hNE (100μg/ml), trypsin (10μg/ml), and an 
hNE inhibitor EPI-hNE4 (44μg/ml), for 2 minutes at room temperature before INa was measured by 
voltage-clamp technique. Shown is relative (relative to untreated ENaC injected oocytes with INa of 
2.7±0.6μA) mean ± S.E. of three independent experiments performed with 6 oocytes per experimental 
condition). ***P<0.001 vs. lane 1, *P<0.05 vs. lane 1, ##P<0.01 vs. lane 2 by the students t-test. 
 
Figure 2. EPI-hNE4 does not inhibit amiloride-sensitive Na+ transport induced by co-
injected hCAP1. Co-expression of αβγhENaC with hCAP1 caused increased INa (lane 2), which 
was not inhibited by EPI-hNE4 (lanes 3-5, concentration indicated), but was inhibited by 100μg/ml 
aprotinin (lane 6, #P<0.05 vs. lane 2 ). Shown is relative (relative to untreated ENaC injected oocytes 
with INa of 3.1±0.8μA) mean ± S.E. of four independent experiments performed with 5 oocytes per 
experimental condition. 
 
Figure 3. hNE does not cleave cell surface expressed αENaC.   Wild-type β, and γrENaC was 
co-injected with V5 tagged αrENaC in Xenopus laevis oocytes. A. Amiloride-sensitive current was 
measured in untreated oocytes (3.1±1.3μA, lane 1), oocytes exposed to 10μg/ml hNE (lane 2), 
10μg/ml hNE in the presence of EPI-hNE4 (lane 3), and non-injected oocytes (lane 4), in 5 
independent experiments. hNE significantly activated ENaC (*P<0.05), and this activation was 
inhibited by EPI-hNE4 (#P<0.05). Cell surface biotinylated proteins (surface) and non-biotinylated 
proteins (total pool) were probed with V5 antibody to detect the V5 tag inserted in the C-terminus of 
αENaC. B. Biotinylated cell surface proteins. Full length 95kD αENaC as well as 80kD and 65kD 
fragments were expressed at the cell surface in ENaC injected oocytes (lanes 1-3). Treatment with 
hNE did not produce any additional cleavage products (lane 2). C. Non-biotinylated protein pool. The 
non-biotinylated protein pool contained full length 95kD αENaC in ENaC injected oocytes (lanes 1-
3). Absence of actin in the biotinylated proteins indicated that no non-biotinylated proteins were 
labeled.  Even quantities of actin in the non-biotinylated proteins indicated even protein loading. 
 
 
Figure 4. hNE does not cleave cell surface expressed βENaC.    Wild-type α, and γrENaC 
was co-injected with V5 tagged βrENaC in Xenopus laevis oocytes. A. Amiloride-sensitive current 
was measured in untreated oocytes (2.7±1.3μA, lane 1), oocytes exposed to 10μg/ml hNE (lane 2), 
10μg/ml hNE in the presence of EPI-hNE4 (lane 3), and non-injected oocytes (lane 4), in 5 
independent experiments. hNE significantly activated ENaC (*P<0.05), and this activation was 
inhibited by EPI-hNE4 (#P<0.05). Cell surface biotinylated proteins (surface) and non-biotinylated 
proteins (total pool) were probed with V5 antibody to detect the V5 tag inserted in the C-terminus of 
βENaC . B. Biotinylated cell surface proteins. Full length 105 kD βENaC was expressed at the cell 
surface in ENaC injected oocytes (lanes 1-3). Treatment with hNE did not produce any additional 
cleavage products (lane 2). C. Non-biotinylated protein pool. The non-biotinylated protein protein 
pool contained the full length βENaC in ENaC injected oocytes (lanes 1-3). Absence of actin in the 
biotinylated proteins indicated that no non-biotinylated proteins were labeled.  Even quantities of actin 
in the non-biotinylated proteins indicated even protein loading. 
 
Figure 5. hNE cleaves cell surface expressed γENaC. Wild-type α, and βrENaC was co-
injected with V5 tagged γrENaC in Xenopus laevis oocytes. A. Amiloride-sensitive current was 
measured in untreated oocytes (3.0±0.9μA, lane 1), oocytes exposed to 10μg/ml hNE (lane 2), 
10μg/ml hNE in the presence of EPI-hNE4 (lane 3), and non-injected oocytes (lane 4), in 5 
independent experiments. hNE significantly activated ENaC (*P<0.05), and this activation was 
inhibited by EPI-hNE4 (#P<0.05). Cell surface biotinylated proteins (surface) and non-biotinylated 
proteins (total pool) were probed with V5 antibody to detect the V5 tag inserted in the C-terminus of 
γENaC (lanes 1-4)  B. Biotinylated cell surface proteins. Full length 87kD γENaC as well as the 76kD 
fragment were expressed at the cell surface in ENaC injected oocytes (lanes 1-3). Treatment with hNE 
resulted in an additional γENaC cleavage product (*, lane 2) relative to the non-treated ENaC injected 
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oocytes (lane 1). The appearance of this additional band was prevented when oocytes were treated 
with the hNE inhibitor EPI-hNE4 and hNE, simultaneously (lane 3).  C. Non-biotinylated protein 
pool. The non-biotinylated protein pool contained the full length 87kD γENaC and the 76kD 
endogenous cleavage product (lanes 1-3).  Absence of actin in the biotinylated proteins indicated that 
no intracellular proteins were labeled.  Even quantities of actin in the intracellular proteins indicated 
even protein loading. 
 
Figure 6 Western blot densitometry of γENaC.  Western blots of biotinylated and non-
biotinylated V5 tagged γENaC were analyzed using a Bio-rad Densitometer, in 5 independent 
experiments. A. Cell surface biotinylated γENaC band intensity was normalized to the 87kD γENaC 
band in untreated ENaC injected oocytes (lane 1). Neither hNE treatment (lane 2), nor treatment with 
hNE and EPI-hNE4 (lane 3) significantly effected the quantity of 87kD γENaC at the cell surface. The 
76kD γENaC fragment was expressed at the cell surface in ENaC injected oocytes (4-6). Neither 
treatment with hNE (lane 5), nor hNE and EPI-hNE4 (lane 6) changed the intensity of the 76kD 
γENaC fragment significantly. There was a significant increase in the intensity of the 67kD γENaC 
fragment when oocytes were treated with hNE (lane 8, * denotes P<0.05), but this band was not 
present in untreated oocytes (lane 7), nor in oocytes treated with hNE in the presence of EPI-hNE4 
(lane 9). B. Non-biotinylated γENaC band intensity was normalized to the 87kD γENaC band in 
untreated ENaC injected oocytes (lane 1). Neither hNE treatment (lane 2), nor treatment with hNE and 
EPI-hNE4 (lane 3) significantly effected the quantity of 87kD γENaC in the non-biotinylated ENaC 
injected oocytes. The endogenously cleaved 76kD γENaC fragment was present in the non-
biotinylated ENaC injected oocytes (4-6). Neither treatment with hNE (lane 5), nor hNE and EPI-
hNE4 (lane 6) changed the intensity of the 76kD γENaC fragment significantly. The 67kD γENaC 
band was not present in the non-biotinylated proteins (lane 7-9). 
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DISCUSSION 
 
Exposure of αβγ injected oocytes to NE caused an increase in INa that was inhibited by the NE 
specific inhibitor EPI-hNE4. Previous work by Mall et al. has shown that increased ENaC 
activity in the mouse lung was sufficient to produce a phenotype similar to CF by reducing 
PCL. Our experiments showed that the serine protease NE which is abundant in the lungs of 
patients with CF is capable of increasing ENaC activity on the same scale (3 fold increase), as 
in the ENaC overexpressing transgenic mice of Mall et al. (23). This 3 fold increase in ENaC 
activity by Mall et al. was sufficient to decrease PCL levels, replicating CF lung disease. This 
suggests that the greater than 3 fold increase in ENaC activity by NE may also be able to alter 
the PCL level in the CF lung. 
 
Patients with CF have a disease phenotype dictated by the following cascade: decreased 
CFTR mediated fluid secretion, decreased PCL leading to impared mucus clearance, airway 
infection and inflammation, which results in neurophil recruitment to the lung. Neutrophils 
recruited to the lung would release NE into the PCL. When CF patients with decreased PCL 
are exposed to NE secreted from neutrophils, ENaC activity would be increased leading to 
further reduction in PCL levels and worsening of the disease. If patients receive NE inhibitor 
therapy, this could stop this positive feedback cycle by preventing further decrease in PCL via 
ENaC. Indeed, elevated NE levels contribute to many pulmonary diseases such as CF, 
emphysema, and COPD. Our findings suggest that stimulation of ENaC and consequent 
reduction in PCL is involved in these diseases. 
 
Inhibition of all proteases in the lung could result in unwanted side effects resulting from 
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inhibiting normal cellular reactions that depend on proteolitic processing. EPI-hNE4 was 
shown to be specific for NE when activation of ENaC by trypsin and the serine protease 
hCAP1 (known to be expressed in lung epithelium) was demonstrated in the presence of the 
inhibitor. A specific inhibition of NE in the CF lung by EPI-hNE4 is a more appropriate 
therapy for a condition where lung physiology is already seriously disturbed. 
 
When NE and trypsin were used simultaneously to activate ENaC, INa was increased. The 
effects of these two serine proteases were not additive or synergistic. This suggests that NE 
and trypsin act through a common mechanism that involves cleavage of the channel or a 
regulatory molecule associated with it. Indeed, biotinylation of cell surface expressed ENaC 
revealed that NE was acting directly on the channel by cleaving γENaC. The α and β ENaC 
subunits were not cleaved, indicating that cleavage of γ ENaC was coordinated and specific 
despite the excessive quantity of NE used (100μg/ml). This is a consistant feature of the 
ENaC subunits. The extracellular loop of the α, β, and γ ENaC subunits contain multiple 
potential cleavage sites, but cleavage is consistently observed only in the γ ENaC extracellular 
loop distal to the H1 region. This provided further evidence that the remainder of the γ ENaC 
subunit as well as the α, and β ENaC subunits are protected from proteolytic cleavage. 
 
Cleavage of the γ ENaC subunit by NE resulted in a 67kD fragment, which corresponds well 
with the size of cleavage product seen in in-vivo experiments (43,44). In-vivo experiments 
indicate cleavage of the γ ENaC subunit appears to be more distal from the N-terminus than 
the reported “furin” cleavage site (43,44). This in-vivo cleavage resulted in a fragment less 
than 70kD, whereas the furin cleavage site demonstrated in cell lines and in the Xenopus 
oocyte resulted in a fragment of 75-76kD (40). The 76kD cleavage fragment was observed in 
the biotinylation experiments, and appeared to be the substrate for the 67kD cleavage product, 
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since the quantity of 76kD band decreased with the increase of the 67kD band. This would be 
consistent with our previous experiments, which showed that the furin cleavage of γ ENaC 
increased the Tmax for activation by trypsin. This also suggests that the proteolytic cascade we 
proposed for ENaC activation could involve multiple steps with a cleavage at the furin site 
producing a 76kD γ ENaC fragment preceeding further cleavage activation at a slightly more 
distal site resulting in a 67-70kD γ ENaC fragment.  
 
In conclusion, we report that elevated NE in pulmonary diseases including CF is capable of 
activating ENaC. This activation of ENaC could further reduce PCL, and contribute to 
pulmonary disfunction. The NE specific inhibitor EPI-hNE4 is capable of preventing 
activation of ENaC, and cleavage of the γ subunit by NE. 
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SerpinH1 is an abundantly expressed protease inhibitor in the distal 
nephron capable of regulating ENaC function. 
 
Aim 3:  
 
Determine if protease inhibitor genes are capable of regulating ENaC function as antagonists 
to serine proteases, which are know to activate ENaC by cleaving the γ subunit. We wished to 
determine which protease inhibitor genes are abundantly expressed in the distal nephron. 
After identifying an abundant protease inhibitor candidate we wanted to test its ability to 
inhibit ENaC in the Xenopus oocyte expression system. 
 
INTRODUCTION 
 
In aldosterone-responsive epithelial cells, ENaC plays a critical role in the control of Na+ 
balance, blood volume, and blood pressure. Recent in-vitro and in-vivo experiments indicate 
that membrane-bound serine proteases (Channel activating proteases, CAPs) or furin may be 
responsible for the activation of ENaC (40-42,79,80,86,94,108). Our general working 
hypothesis postulates the existence of a complex intra- and extra-cellular pathway involving 
different CAPs and serine proteases inhibitors that will activate or prevent activation of ENaC 
by controlling its assembly and/or trafficking to the apical membrane of epithelial cells, 
through cleavage events. Recently, PN-1 was identified as a protease inhibitor capable of 
inhibiting ENaC stimulation by prostasin (109), indicating that protease inhibitor genes have 
an influence on ENaC activity. However, this study failed to identify if cleavage of the ENaC 
subunits was prevented by PN-1. It has been shown that the γ (but not α or β) ENaC subunit 
is a direct substrate for serine proteases and is cleaved at specific sites in the extracellular 
domain. We hypothesized that endogenously expressed protease inhibitors in the distal 
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nephron may be involved in suppressing subunit cleavage resulting in decreased ENaC 
activity. Specifically, we propose that serine protease inhibitors are capable of preventing 
cleavage of γ ENaC at the cell surface. In order to identify potential protease inhibitor 
candidates we screened several transcriptome libraries of the cortical collecting duct (CCD) to 
identify serine protease inhibitors that may be potential regulators of ENaC. We identified 
serpinH1 as one of the most abundant serine protease inhibitors of the CCD. SerpinH1 is a 
serine protease inhibitor that has been shown to have multiple functions leading to its 
alternative identities heat shock protein 47 (HSP47), and collagen binding protein 1 (CBP1). 
Interestingly, serpinH1 is known to be induced by TGFβ (110,111).  The other serpin known 
to effect ENaC function, PN-1 is also induced by TGFβ (109). TGFβ has been shown to 
antagonize the effect of aldosterone in the distal nephron (112).  
 
HYPOTHESIS 
 
We wished to identify abundantly expressed protease inhibitor genes in the distal nephron. 
Specifically we hypothesized : 
1. Serine protease inhibitor genes are expressed in the distal nephron. 
2. These protease inhibitor genes can inhibit ENaC activity by preventing cleavage of the 
γ subunit. 
 
RESULTS 
 
Three different sources of distal gene expression were used to identify protease inhibitor 
genes abundantly expressed in the distal nephron. An affymetrix gene expression profile of a 
novel CCD cell line generated in our laboratory (113), a mpkCCD serial analysis of gene 
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expression (114), and a human nephron SAGE (115), were used to identify abundantly 
expressed serine protease inhibitor genes in the distal nephron. SerpinH1 was identified as the 
most abundant and consistently expressed serine protease inhibitor gene of the distal nephron. 
SerpinH1 has been linked to a quantitative trait locus for salt-sensitive hypertension (116), 
suggesting that it could be involved in the regulation of ENaC in the distal nephron. 
 
The mouse serpinH1 gene was ordered from the Image consortium and Mammalian Gene 
Collection (117). The serpinH1 coding sequence was excised with Sal I and Not I and inserted 
into pSDeasy plasmid, so that cRNA could be synthesized. SerpinH1 and ENaC cRNA was 
injected into Xenopus oocytes in order to study the effect of serpinH1 on ENaC. When 
serpinH1 was co-expressed in Xenopus oocytes with ENaC, it significantly decreased basal 
ENaC activity by 50% (p<0.001) when oocytes were incubated overnight in 4μl/oocyte of 
MBS buffer (Figure 10). When oocytes were incubation in 400 μl/oocyte of MBS buffer, 
there was no effect of co-injecting serpinH1 on ENaC activity (Figure 10). This suggested that 
serpinH1 was secreted into the medium, and was effective in the low volume experiments, but 
too dilute in the high volume experiments. ROMK is a cation channel co-expressed with 
ENaC at the apical membrane of CCD. SerpinH1 did not inhibit barium-sensitive currents in 
oocytes injected with ROMK cRNA in low volume conditions, indicating that it was 
selectively inhibiting ENaC activity (Figure 11). 
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Figure 10: SerpinH1 decreases ENaC activity. When cRNA for serpinH1 was co-injected in 
Xenopus oocytes with ENaC, it significantly decreased basal ENaC activity by >50% (* 
p<0.001, n=6) when oocytes were incubated overnight in 4μl/oocyte of MBS buffer (low 
volume). When oocytes were incubation in 400 μl/oocyte of MBS buffer (high volume), there 
was no effect of co-injecting serpinH1 on ENaC activity (n=6).  
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Figure 11: SerpinH1 did not inhibit ROMK. Co-injection of Xenopus oocytes with ROMK 
and serpinH1 cRNAs did not effect barium-sensitive currents (n=2).  
 
Cell surface biotinylation was performed in oocytes injected with α, β, V5 tagged γ ENaC and 
serpinH1 cRNAs, and subjected to western blotting. Co-injection of serpinH1 with ENaC 
decreased cleavage of γ ENaC at the cell surface (Figure 12A). Four independent western 
blots were analyzed by densitometry, co-expression of serpinH1 caused a greater than 60% 
decrease in cleavage of the γ ENaC subunit (p<0.01). There was a 35% decrease in full-length 
γ ENaC at the cell surface that did not reach statistical significance (Figure 12B).  
 
The non-biotinylated protein pool contained predominantly the full length 87kD γ ENaC  
band with smaller amounts of the cleaved 76kD band (Figure 13A). Four independent western 
blots of the non-biotinlated proteins were analyzed by densitometry (Figure 13B). There were 
equal amounts of the full-length 87kD γ ENaC in the non-biotinylated protein pool suggesting 
that serpinH1 was not inhibiting subunit translation. There was less 76kD γ ENaC in the non-
biotinylated protein pool that did not reach statistical significance.   
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Figure 12: SerpinH1 decreased cleavage of biotinylated cell surface expressed γ ENaC. 
Oocytes injected with α, β,  V5 tagged γ ENaC and co-injected with serpinH1 cRNAs were 
biotinylated and western blotted. A, co-injection of serpinH1 decreased cleavage of the γ 
ENaC subunit at the cell surface. Absence of actin in the biotinylated proteins confirmed that 
only cell surface proteins were labeled. B, The amount of 87kD and 76kD band was 
quantified in four independent experiments. There was less 76kD cleavage product when 
serpinH1 was co-injected with ENaC (* p<0.01).  
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Figure 13: SerpinH1 did not decrease cleavage of non-biotinylated cell surface expressed γ 
ENaC. Oocytes injected with α, β,  V5 tagged γ ENaC and co-injected with serpinH1 cRNAs 
were biotinylated and western blotted. A, co-injection of serpinH1 did not decrease cleavage 
of the γ ENaC subunit at the cell surface. B, The amount of 87kD and 76kD band was 
quantified in four independent experiments. There was equal amounts of 87kD and 76kD γ 
ENaC when serpinH1 was co-injected with ENaC.  
 
αβγ ENaC
SerpinH1
+
-
+
+
-
-
87kD 
76kD 
Actin
+ +
αβγ ENaC 
SerpinH1 
+
-
+ -
- - -
+ + -
76kD 87kD 
D
en
si
to
m
et
ry
 
A. 
B. 
1.0
0.8
1.2
0.6
0.4
0.2
- 107 - 
After demonstrating that serpinH1 was an abundant serine protease inhibitor expressed in the 
distal nephron capable of inhibiting ENaC activity and γ ENaC cleavage in the Xenopus 
oocyte, we wished to examine a more physiologic role for this gene. It has been demonstrated 
that serpinH1 is induced by transforming growth factor-β1 (TGFβ) (110,111). It has also been 
shown that TGFβ can inhibit aldosterone mediated increases in ENaC activity in inner 
medulary collecting duct cells (IMCD). This inhibition did not affect the increased α ENaC 
expression induced by aldosterone (112,118). We speculated that TGFβ could induce 
serpinH1 expression in the CCD and prevent cleavage and activation of γ ENaC as observed 
in the Xenopus oocyte. To test this hypothesis we exposed mCCD cells to aldosterone and 
TGFβ for 24 hours.  Monolayers of mCCD cells were exposed to aldosterone at 
concentrations of 0.3nM and 300nM, in order to examine mineralcorticoid vs. glucocorticoid 
receptor specificity (113), with respect to inhibition by TGFβ. Both the 0.3nM and 300nM 
doses of aldosterone were inhibited by 20ng/ml (800pM) TGFβ (p<0.001, n=6, Figure 14). 
The inhibition of aldosterone by TGFβ lasted until the end of the 24 hour study period.  
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Figure 14: TGFβ (20ng/ml or 800pM) prevented aldosterone mediated stimulation of ion 
transport (measured as short circuit currents per cm2 of cells, Isc) in mCCD cells. Aldosterone 
stimulated Isc in mCCD cells at a concentration of 0.3nM (p<0.01, small white circle), and 
300nM (p<0.001, large white circle), over untreated cells (x). TGFβ alone (black square) did 
not effect Isc. TGFβ blocked the response to 0.3nM aldosterone (p<0.05, small black circle), 
and 300nM aldosterone (p<0.001, large black circle). Resistance of the monolayers was 
always above 1000Ω/cm2 before and after treatments. n=6 for all groups. 
 
 
A dose response curve from 0.5ng/ml to 20ng/ml (20 to 800 pM) TGFβ was tested against a 
0.3nM dose of aldosterone (Figure 15). The IC50 of TGFβ against 0.3nM aldosterone was 
lower than 0.5ng/ml over 24 hours, since the 0.5ng/ml dose completely blocked the 
aldosterone response (p<0.001). After the 24 hour incubation period, the mCCD cells were 
rinsed and fed minimal medium. After changing the medium, cells treated with TGFβ (all 
doses) and aldosterone had a greater than four fold increase in Isc (p<0.001), whereas 
untreated and aldosterone treated cells did not. The “rebound effect” after treatment with 
aldosterone and TGFβ was first detected after eight hours and peaked 24 hours after the 
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medium change (p<0.001). The rebound was reduced but present after 48 hours for all doses 
(p<0.001), and 72 hours for 10 and 20 ng/ml doses (p<0.001). 
 
Figure 15: TGFβ prevented stimulation of Isc in mCCD cells in a dose response manner, and 
washout of TGFβ after 24 hours resulted in a large increase in ion transport. Aldosterone 
stimulated Isc in mCCD cells at a concentration of 0.3nM (p<0.05, white circle) over untreated 
cells (x). TGFβ blocked the response to 0.3nM aldosterone (p<0.001 all doses, black circles, 
size of circle represents dose as in legend). After 24 hours medium was removed from the 
apical and basolateral sides of the monolayers and the monolayers were rinsed and replaced 
with minimal medium. Cells treated with aldosterone and TGFβ had increased Isc after the 
medium change which peaked after 24 hours (p<0.001), and lasted 48 hours (p<0.001). 
Resistance of the monolayers was always above 1000Ω/cm2 before and after treatments. n=3 
for all conditions. 
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DISCUSSION 
 
SerpinH1 is a serpin serine protease inhibitor. It is also known as collagen binding protein 1 
(CBP1), vaspin, heat shock protein 47 (HSP47), and gp46 (119). SerpinH1 is a serine (or 
cysteine) protease inhibitor that has been shown to be involved in collagen binding in renal 
fibrogenesis (120,121). Under stress conditions, serpinH1 has been shown to translocate to the 
cell surface (122,123), and is excreted into the apical medium of cultured cells (124). The 
primary AA sequence of serpinH1 predicts  motifs for a signal sequence, a serpin domain, and 
an endoplasmic reticulum (ER) retention signal (Figure 16) (125). 
 
Figure 16: Motifs present in the primary sequence of serpinH1. The amino terminus (N) of 
the protein contains a signal sequence (white box) from AA’s 1-8, followed by a serpin 
domain (grey box) from AA’s 36-409, and a RDEL ER retention signal (black box) from 
AA’s 415-418 at the carboxy terminus (C). 
 
Co-injecting cRNA of serpinH1 into Xenopus oocytes with ENaC caused a decrease in ENaC 
activity. Co-injection of serpinH1 with ROMK did not affect barium sensitive currents 
through ROMK, suggesting that the effect on ENaC was specific, and was not an unspecific 
effect on the oocyte ion transport, or protein synthesis capabilities. Injection of serpinH1 with 
ENaC caused inhibition of γ ENaC cleavage at the cell surface without affecting the 
abundance of the 87kD non-biotinylated intracellular protein. The small but significant 
decrease in the 76kD γ ENaC band in the non-biotinylated protein pool most likely 
represented surface subunit that was not efficiently biotinylated.  
 
SerpinH1 N- -C
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Cleavage of the γ ENaC subunit has been demonstrated with furin (40), although other serine 
proteases have been shown to induce cleavage in  γ ENaC as well (42,92,126). There are only 
two serpins that have been shown to inhibit furin, Spn4a and serpinB8 (127,128). Both Spn4a 
and serpinB8 contain a furin consensus site (RXXR) in their reactive site loops at AA’s 371-
375 and 336-342 respectively, which are thought to target furin (127,128). Analysis of the AA 
sequence of serpinH1 revealed the presence of the furin consensus motif RLVR at AA’s 404-
407 of the reactive site loop.  
 
This data indicates that serpinH1 could be the third serpin that is capable of inhibiting 
proprotein convertases such as furin, although further experiments demonstrating furin-
serpinH1 covalently linked complexes would be required to prove this. Both serpinH1 and 
Spn4a have ER retention signals as well as signal sequences that suggest that they are capable 
of cycling between the ER and to the secretory pathways of the cell (127), similar to furin 
(129). This suggests that SerpinH1 may be in the correct location to inhibit furin in-vivo, and 
thereby prevent activation of ENaC. It is also possible that serpinH1 is inhibiting other serine 
proteases that are cleaving the γ ENaC subunit. 
 
SerpinH1 was identified as a gene overexpressed by high salt diet in the Sabra spontaneously 
hypertensive rat (116). Expression of serpinH1 is known to be induced by TGFβ in multiple 
cell types including kidney mesengial cells (110,111,124). High salt diet has been shown to 
increase expression of TGFβ in the kidney (130,131). Therefore, the induction of serpinH1 by 
TGFβ in conditions of salt excess may be responsible for suppression of ENaC activity when 
Na+ is not required. It has previously been shown that TGFβ can inhibit the stimulatory effect 
of aldosterone on ENaC activity in the kidney (118), without effecting anion secretion (132), 
or the ability of aldosterone to increase α ENaC gene expression (112). TGFβ has also been 
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shown to decrease the amount of aldosterone secretion by the adrenal glands (133,134). 
Together these studies suggested that TGFβ was counteracting the effect of aldosterone in the 
kidney by inhibiting activation of ENaC. Since TGFβ is known to induce the expression of 
serpinH1 which we have shown to inhibit ENaC, we wished to study this mechanism in the 
mCCD. To investigate this effect, mCCD cells were treated with aldosterone and TGFβ 
simultaneously. As shown in other distal nephron cell types, TGFβ was capable of inhibiting 
the effect of aldosterone on Isc. However, the mCCD cells are responsive to lower more 
physiological doses of aldosterone (0.3nM) that are typical of mineralcorticoid receptor 
specificity (113). We demonstrated for the first time that TGFβ was capable of inhibiting the 
effect of low dose (mineralcorticoid receptor), and high dose (mineralcorticoid and 
glucocorticoid receptors) aldosterone. Furthermore, dose response studies revealed that TGFβ 
was capable of complete inhibition of low dose 0.3nM aldosterone at a concentration of less 
than 0.5ng/ml (<20pM). This concentration was much lower than the effective concentration 
used in previous studies where hyper-physiological concentrations of aldosterone were 
necessary to induce Isc, and suggest that a physiologic dose of TGFβ (135,136) is sufficient to 
block the aldosterone response. 
 
Our experiments and previous studies suggest that aldosterone increases ENaC translation, 
and that TGFβ can block ENaC activity. We propose that upon stimulation with aldosterone 
and TGFβ, mCCD cells increase the quantity of ENaC protein, but that this protein remains 
inactive. There are several possible mechanisms by which TGFβ could keep ENaC inactive 
after aldosterone stimulation. The most obvious would be prevention of insertion of the 
channel complex into the cell surface, and the cleavage activation of the γ ENaC subunit.  
 
Since TGFβ is known to induce serpinH1 expression, it is tempting to speculate that TGFβ is 
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acting on ENaC by preventing the cleavage activation of the γ ENaC subunit via serpinH1. 
The insertion of the ENaC complex into the cell membrane was studied in the Xenopus 
oocyte, and although not significant, it was slightly affected by co-expression of serpinH1. 
The cleavage activation of γ ENaC subunit in the oocyte was the largest and most significant 
consequence of co-injecting serpinH1. This suggests that TGFβ is preventing cleavage 
activation of ENaC at the cell surface via serpinH1. However, this effect is likely more global 
and involves other serpins. TGFβ is also known to induce the expression of serpins PN-1 and 
SerpinE1 in the kidney (109,137). Together these results suggest that TGFβ may be involved 
in proteolytic protection in the kidney, which results in decreased ENaC activity. 
 
Perhaps the most provocative result of these experiments was the “rebound effect” seen when 
medium was removed from aldosterone and TGFβ treated cells. This rebound resulted in a 
four fold increase in Isc. This increase in Isc occurred after eight hours, peaked at 24 hours, and 
lasted up to 48 hours after medium change.  Most serpins, including serpinH1 are secreted 
from the apical membrane into the extracellular milieu (124). Serpins are also irreversible 
suicide substrate inhibitors of proteases (78). Serpins secreted from the apical membrane 
would inactivate all surface expressed serine proteases permanently. Removal of the apical 
medium in mCCD cells would effectively remove these protease inhibitors. After removal of 
the serpins, de novo synthesis and insertion of serine proteases in the apical membrane could 
activate ENaC present at the apical cell membrane.  
 
In a previous study by Husted et al., the effect of TGFβ inhibition of aldosterone in an IMCD 
cell line lasted 48 hours after removal (118), which is in disagreement with our data. Our data 
indicate that removal of medium resulted in a four fold increase in Isc after 24 hours, at doses 
higher and lower than the dose (400pM)  used in the IMCD cell line study. The different cell 
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types may account for this difference. However, TGFβ is extremely hydrophobic and it is 
possible that it was not completely removed from the IMCD cells by medium change. The 
large “rebound effect” seen by removal of aldosterone and TGFβ seen in our experiments 
suggests that there was a large pool of ENaC protein induced by aldosterone and retained in 
an inactive/unproteolytically processed state by the induction of protease inhibitors such as 
serpinH1. This large pool of unproteolytically processed ENaC would then be activated upon 
removal of the serpins in the apical medium. 
 
In summary, serpinH1 is expressed in the collecting duct, inhibits ENaC function, and 
prevents γ ENaC cleavage. The induction of protease inhibitors serpinH1, PN-1, and serpinE1 
by TGFβ in the distal nephron may be responsible for controlling ENaC activity. Our findings 
may be relevant to the genetic basis of hypertension since serpinH1 was recently identified as 
a novel gene implicated in the Sabra rat model of salt-sensitive hypertension (116). 
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Future Studies and Perspectives 
Perspectives 
 
Cleavage of γ ENaC subunit occurs at the cell surface when the αβγ subunits are co-expressed 
resulting in high ENaC currents, whereas co-expression of α and γ subunits results in αγ 
channels that are not cleaved and have low activity. Trypsin and NE are capable of activating 
the low activity αγ channels more than four fold. This cleavage activation via γ ENaC 
involves proteases expressed in the Xenopus oocyte, MDCK kidney cell line, CHO cells, the 
in-vivo lung, and in-vivo kidney after low salt diet, as previously discussed. Mutation of the 
furin cleavage site in γ ENaC, the use of the furin inhibitor αPDX, and co-expression with the 
serine protease inhibitor serpinH1 decreased cleavage of γ ENaC subunit reducing the 
quantity of the 76kD furin cleavage fragment. These results suggest that cleavage of γENaC 
subunit is responsible for the activation of ENaC.  
 
Although these techniques mentioned above which inhibit ENaC cleavage activation appear 
to be furin specific, this is not necessarily the case. There are several arguments suggesting 
that furin may not be involved in ENaC cleavage activation. Firstly, the effect of furin 
inhibition may be non-specific since furin is involved with multiple essential cell functions 
(74). Inhibition of furin could be affecting many processes, including the processing and 
activation of other serine proteases capable of activating ENaC.  
 
Secondly, the furin consensus motif (RXXR) is not specific to furin. This consensus motif is 
common to all proprotein convertases, and is very similar to the CAP1 consensus motif (R/K-
H/R/K-X-R-X-X-X-S/A) (92), suggesting that these proteases are capable of cleaving at this 
- 116 - 
same site. Sequence analysis of the of α and γ ENaC subunits reveals that the furin cleavage 
site is compatible with cleavage by CAP1 for the γ but not the α subunit (Figure 17). 
Furthermore, the furin consensus motif contains R and K AA’s known to be the target of 
trypsin. Mutational inactivation of this site in  γ ENaC provides evidence that it is involved in 
the cleavage cascade, but does not indicate that it is specific to furin. This suggests that furin 
may not be acting directly on ENaC but by processing other proteases, or other proteins that 
activate proteases, etc. 
 
 
Figure 17: The furin consensus site (RXXR) is also a CAP1 consensus site (R/K-H/R/K-X-R-
X-X-X-S/A) in the γ but not the α ENaC subunit (black boxes highlight the motifs). The rat 
(R), mouse (M), and human (H) α and γ ENaC subunits were aligned using Clustal X. The 
two furin sites in the α ENaC subunit in these three species is not compatible with CAP1 
cleavage since the consensus is broken at the second AA residue, which is not an H, R, or K, 
and not conserved among species (RXXRDLXG, RXARSXXS). The furin site in the γ ENaC 
subunit in these three species is compatible with CAP1 cleavage since the consensus site 
RKRREAXS is conserved. 
 
It is possible that furin, CAP1, or another protease capable of cleaving at the RXRR site in γ 
ENaC, could be involved in a complex cleavage cascade. Cleavage at the furin consensus 
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motif may facilitate downstream activation by other proteases. This was demonstrated by our 
observation that Tmax by trypsin was increased when this cleavage was prevented. Further 
evidence was provided when NE was shown to induce a 67kD  γ ENaC fragment while 
reducing the abundance of the 76kD  γ ENaC fragment. This suggests that although cleavage 
at the furin consensus site is capable of activating ENaC, and may be involved in the 
proteolytic cascade, it is not the only cleavage site in the γ ENaC subunit capable of activating 
ENaC.  
 
 
Cleavage of the α ENaC subunit in our experiments was not consistent and did not correlate 
with channel activity. This suggests that α ENaC cleavage may be a result of channel 
processing or degredation. This is supported by in-vivo experiments where cleavage of the γ 
ENaC subunit corresponds with increased channel activity (43). Athough cleavage of both the 
α and γ ENaC subunits has also been observed (44). The major difference between the 
cleavage of the α and γ ENaC subunits in-vivo is the the precursor-product relationship for γ 
the subunit but not the α subunit (43,44). When ENaC activity is increased there is a shift in 
molecular weight of the  γ ENaC subunits from 87kD to 67-70kD, whereas the full 
length α ENaC and its cleavage products are increased in parallel, without a change in this 
ratio. This suggests that the γ ENaC subunit cleavage, which correlated with channel 
activation in-vitro has the same effect in-vivo. The α ENaC cleavage is most likely a 
processing or degradation event unrelated to activation. 
 
Our observation that NE is capable of inducing a smaller γ ENaC cleavage fragment more 
distal than the furin cleavage site, further support the cleavage cascade model. This 
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“proteolytic cascade” is involved in ENaC activation, where proteolytic cleavage of the 
channel by furin or other serine proteases acts to facilitate future cleavage events that increase 
channel activity. This “proteolytic cascade” model could involve the CAPs, trypsin, 
chymortrypsin, NE, as well as other unidentified proteases co-expressed with ENaC (Figure 
18). 
 
Activation of ENaC by NE suggests that this “proteolytic cascade” could be involved in CF 
related decreases in PCL. The inhibition of NE mediated stimulation of ENaC by EPI-hNE4 
demonstrates that inhibiting this “proteolytic cascade” could be beneficial to CF patients, and 
prevent a previously unkown ion transport defect. Cleavage of γ but not α or β ENaC by NE 
suggests that cleavage of ENaC by serine proteases is not due to random cleavage of all 
surface expressed molecules, but involves specific cleavage of only the γENaC subunit in a 
specific region proceeding the H1 domain. 
 
The identification of serpinH1 as an inhibitor of  γ ENaC cleavage is intriguing, as the serine 
protease, serine protease inhibitor balance is likely involved in the regulation of ENaC (Figure 
19). It is possible that induction of serpinH1 and other serine protease inhibitors PN-1, and 
serpinE1 by TGFβ in-vivo play an essential role in ENaC regulation. This regulation of 
protease inhibitors by TGFβ could be the mechanism by which TGFβ inhibits aldosterone in 
the distal nephron. In order to confirm this hypothesis, further studies are required. 
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Figure 18: The γ ENaC subunit is cleaved in two locations. The previously described furin 
cleaveage site is also a consensus site for several proprotein convertases as well as prostasin 
(CAP1). Cleavage at this location leads to low channel activity. The low activity channel is 
capable of being converted to a high activity channel by prostasin (CAP1), CAP2, CAP3, 
trypsin, chymotrypsin, and elastase. The conversion from low activity to high activity has 
been shown to be accompanied by a second more distal cleavage in the extracellular loop by 
elastase (126),  and prostasin (CAP1)(42). 
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Figure 19: Serine protease inhibitors may prevent cleavage activation of the γ ENaC subunit. 
As we have demonstrated, SerpinH1 can prevent the cleavage of the γ ENaC subunit, and 
reduce channel activity. Serpins Spn4A and SerpinB8 are also known to inhibit furin and may 
play a role in cleavage activation prior to insertion of the channel into the cell surface. The 
serine protease inhibitors aprotinin, and PN-1 have been shown to decrease channel activity.  
The elastase specific inhibitor EPI-hNE4 has been shown to specifically inhibit elastase 
activation of ENaC as well as cleavage of the γ ENaC subunit at the cell surface. Perhaps 
serpinE1, a protease inhibitor expressed in tisues containing ENaC could also play a role in 
regulating channel function. 
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The recent progress in determining the cleavage activation of ENaC by us and others is a 
significant advance in the understanding of a complex and highly regulated channel. The 
implication of serine proteases in the control of Na+ balance has important implications for 
the development of new medications for hypertension and pulmonary diseases. If serine 
protease inhibitors are capable of inhibiting ENaC mediated Na+ absorption in the kidney, 
they have the potential to be developed as medications to control hypertension. However, 
serine proteases perform multiple essential functions in the body, and non-specific inhibition 
of all serine proteases could be very detrimental. It would be important to identify specific 
inhibitors that could prevent activation of ENaC but not affect other cellular functions 
attributed to serine proteases. The advancement of pharmacogenomics has revelaed that 
hypertension is due to different genetic causes such as mutation of ENaC, g-protein coupled 
receptors, and ACE (138). Screening hypertensive patients for mutations in serine protease 
and serine protease inhibitor genes may indicate that some hypertensive patients have 
inappropriate stimulation of ENaC by serine proteases. Protease inhibitor therapy for these 
patients may be more appropriate than medications currently available. Protease inhibitors are 
already in the late stage clinical trials for the treatment of NE mediated degradation in CF and 
COPD. Perhaps the recently elucidated role of NE of ENaC will lead to further indications for 
these medications in other respiratory diseases. 
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Future Studies 
 
It would be interesting to examine the cleavage of αβ vs. αγ ENaC in the Xenopus oocyte. We 
have shown that αβ channels cannot be activated by trypsin or NE, but that αγ channels can 
be activated by both trypsin and NE. It would be insightful to examine the cleavage status of 
the γ ENaC subunit at the cell surface in αγ injected oocytes. Pilot experiments have revealed 
that αγ channels have full length 87kD γ ENaC subunit expressed at the cell surface, and 
exposure to NE resulted in the formation of the 67kD γ ENaC NE cleavage product. What is 
more interesting is that the 76kD γ ENaC cleavage intermediate was not observed suggesting 
that cleavage at the “furin” consensus site was not required for channel activation in the αγ 
channel. This approach could also be used to determine if the α ENaC subunit could be 
cleaved in oocytes injected with αβ or α subunit alone, since we have demonstrated that these 
channel complexes can travel to the cell surface in the Xenopus oocyte. 
 
To confirm the role of γ ENaC cleavage at the cell surface in channel activation it would be 
interesting to take alternative approaches. Such approaches could include the use of 
differential high speed centrifugation and urinary exosomes to examine the cleavage status of 
ENaC in-vivo. A recent study indicated that differential centrifugation was used to isolate 
vesicular, and membrane pools of ENaC (139). Although this study did not examine the 
effects of aldosterone or low salt diet that have been known to increase the abundance of the γ 
ENaC cleavage product, it demonstrated that these techniques are possible and can be used to 
study ENaC cleavage in these discrete cellular compartments. Initial studies with urinary 
exosomes have revealed that γ ENaC secreted in the urine is cleaved (140). Further studies 
with urinary exosomes of animals subjected to high salt and low salt diets could provide 
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further information about the cleavage activation relationship of ENaC. Using these 
techniques, the cleavage status of ENaC can be further assessed independent of the results we 
obtained by biotinylating surface expressed channels. This would provide an alternative 
approach to observe the cleavage events involved in ENaC activation. 
 
To determine if cleavage and activation of ENaC occurs in CF patients due to elevated NE 
levels, pulmonary epithelial cells should be used to evaluate the cleavage in a more 
physiologically relevant cell type. These experiments are planned to be performed in 
collaboration with Carol Planes, where electrophysiological measurements and cell surface 
biotinylation would be performed simultaneously in pulmonary epithelial cells.  
 
It is likely that cleavage of ENaC is involved in other diseases characterized by the imbalance 
of proteases and inhibitors. The most notable example is α1-antitrypsin deficiency (76), which 
involves the inactivation of the α1-antitrypsin gene and results in a severe pulmonary 
phenotype (75) similar to CF. The treatment of CF with aerosolized α1-antitrypsin was shown 
to improve PCL levels (141), consistent with the effect we observed with EPI-hNE4. This 
suggests a similar mechanism of action between these two diseases involving ENaC. To date 
there are not any published studies examining the role of ENaC in α1-antitrypsin deficiency. 
 
The contribution of the CAP’s to ENaC activation should also be determined by 
electrophysiological measurement and cell surface biotinylation experiments in the oocyte. 
These experiments will determine if these proteases are also capable of cleaving ENaC. It has 
already been demonstrated that CAP1 is capable of cleaving γ ENaC (42). The ability of the 
CAP 2 and CAP3 to cleave ENaC also needs to be determined.  
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The role of serpinH1 and other protease inhibitors co-expressed with ENaC in-vivo is another 
interesting possibility for future studies. The identification of other serpins besides serpinH1 
and PN-1 capable of inhibiting ENaC activity would help to understand how this channel is 
regulated in-vivo. SerpinE1 is a promising candidate since it is expressed in the distal nephron 
and induced by TGFβ. TGFβ also induces the expression of serpinH1 and PN-1. It is possible 
that there are more serpins induced by TGFβ and capable of regulating ENaC function, and 
these should be investigated. Using our current approach, serpin gene expression could be 
screened in the distal nephron gene expression libraries that we have used. Promising 
candidates could be tested in the Xenopus oocyte for their ability to inhibit ENaC. Induction 
of serpin gene expression in the mCCD cells by TGFβ could then be examined. It would be 
interesting to further study the inhibition of the aldosterone response by TGFβ in lieu of our 
recent results, which indicate that this signaling pathway may involve the proteolytic 
protection of γ ENaC by serpins. 
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